{"meta":{"query_hash":"6cbc46beb1ad","filters":{"venue":"Cancer Research Communications"},"cohort_total":66,"direct_labels_cover":0,"predictions_cover":66,"exported":66,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6cbc46beb1ad","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Research+Communications"},"results":[{"id":"W3213169138","doi":"10.1158/2767-9764.crc-21-0064","title":"BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin","year":2021,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"Kurozumi Medical Foundation; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Nakatomi Foundation","keywords":"Olaparib; Gene knockdown; Transactivation; Synthetic lethality; Poly ADP ribose polymerase; Cancer research; PARP inhibitor; Biology; Transcription factor; Molecular biology; RAD51; Homologous recombination; Chemistry; Cell culture; DNA repair; Gene; Genetics; Polymerase","score_opus":0.16309682700075723,"score_gpt":0.4551863214761788,"score_spread":0.2920894944754216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213169138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7652189,0.016005455,0.0004985658,0.20902942,0.00009661501,0.0014383135,0.00017076397,0.00009255434,0.007449377],"genre_scores_gemma":[0.98358434,0.009919675,0.002013478,0.0019969854,0.000066762375,0.0010976545,0.00010870891,0.000033467546,0.0011789047],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977948,0.00045987085,0.00039980398,0.00038226938,0.0005808022,0.00038242366],"domain_scores_gemma":[0.9968111,0.00057986786,0.000046506724,0.0014709034,0.0008246051,0.0002670432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008964342,0.00012699135,0.0002561622,0.0003891871,0.00028263574,0.000056035366,0.0003067348,0.000113155285,0.00030678062],"category_scores_gemma":[0.0005140935,0.00014034822,0.000043394284,0.002161759,0.0002769283,0.00017058046,0.00014764485,0.00080228795,0.000031568816],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023053088,0.0017368037,0.103007324,0.00086634106,0.00036823546,0.00009131743,0.031167015,0.00014704053,0.7200918,0.0068042357,0.100983456,0.0324311],"study_design_scores_gemma":[0.011451767,0.0003139932,0.10302289,0.0052157217,0.000057898094,0.000016348544,0.006760971,0.0036125453,0.20639078,0.00617364,0.656085,0.0008984247],"about_ca_topic_score_codex":0.00044800795,"about_ca_topic_score_gemma":0.009073807,"teacher_disagreement_score":0.5551016,"about_ca_system_score_codex":0.0007294873,"about_ca_system_score_gemma":0.0009295287,"threshold_uncertainty_score":0.57232344},"labels":[],"label_agreement":null},{"id":"W4200247581","doi":"10.1158/2767-9764.crc-21-0099","title":"Influence of Germline<i>BRCA</i>Genotype on the Survival of Patients with Triple-Negative Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"National Cancer Institute; Breast Cancer Research Foundation; Conquer Cancer Foundation; Avon Foundation for Women; American Cancer Society","keywords":"Triple-negative breast cancer; Breast cancer; Genotype; Germline; Oncology; Medicine; Triple negative; Internal medicine; Cancer; Biology; Genetics; Gene","score_opus":0.11314913289926067,"score_gpt":0.43653980548928767,"score_spread":0.323390672590027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200247581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97700393,0.0018815437,0.000014222428,0.017212838,0.00004056425,0.000746943,0.00095939677,0.000015427458,0.0021251251],"genre_scores_gemma":[0.9931583,0.005405006,0.00018209375,0.00026372037,0.00004009006,0.0005819941,0.00004927397,0.000026266687,0.0002932831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759495,0.0006130775,0.00035139624,0.00022094008,0.0009536388,0.0002660209],"domain_scores_gemma":[0.99216855,0.00093374983,0.00016457423,0.002122228,0.0045048296,0.00010606733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006114855,0.00012044737,0.00029381755,0.00010365273,0.00025858087,0.000011582729,0.0006611827,0.00005695964,0.0005638708],"category_scores_gemma":[0.00025814003,0.00008304169,0.00006584571,0.0013639765,0.0010277658,0.00008517049,0.00022767692,0.00066612265,0.000008545408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015053213,0.008078852,0.79514986,0.0014307196,0.004067618,0.000018017747,0.011739048,0.011460722,0.064015366,0.057800476,0.0109276865,0.020258442],"study_design_scores_gemma":[0.0054254653,0.00044902955,0.9500198,0.0027197595,0.0001004342,0.0000032896048,0.0009588673,0.0003189616,0.034382727,0.0008197177,0.0045762346,0.00022571956],"about_ca_topic_score_codex":0.0015007362,"about_ca_topic_score_gemma":0.0009580609,"teacher_disagreement_score":0.15486996,"about_ca_system_score_codex":0.00034640057,"about_ca_system_score_gemma":0.0017818878,"threshold_uncertainty_score":0.61739904},"labels":[],"label_agreement":null},{"id":"W4206023678","doi":"10.1158/2767-9764.crc-21-0032","title":"Association of PD-L1 Expression on Tumor and Immune Cells with Survival in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Assay Validation","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"AstraZeneca","keywords":"Durvalumab; Head and neck squamous-cell carcinoma; PD-L1; Medicine; Oncology; Immune system; Biomarker; Immune checkpoint; Cancer research; Internal medicine; Immunotherapy; Head and neck cancer; Cancer; Immunology; Biology; Nivolumab","score_opus":0.094955199636439,"score_gpt":0.39300963255965166,"score_spread":0.29805443292321265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206023678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838008,0.012224963,0.0000042507263,0.0026238775,0.00003904833,0.0008152597,0.00009325281,0.000008791396,0.00038972468],"genre_scores_gemma":[0.99463975,0.0040190932,0.00037023268,0.00004206524,0.0000093252975,0.00041848188,0.000054390406,0.000017185148,0.00042948834],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99770397,0.0010582944,0.00028282963,0.0002157559,0.00052850804,0.00021065235],"domain_scores_gemma":[0.99804455,0.0009826676,0.0001583061,0.0005752513,0.00016738415,0.00007183945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002011281,0.00010107862,0.00024451775,0.00021542955,0.000348695,0.000028623535,0.00017669196,0.00002581633,0.00009652098],"category_scores_gemma":[0.000121739875,0.00008170832,0.000021945765,0.0005016601,0.00018324837,0.00007761274,0.00027941196,0.00051189034,3.0834437e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03384059,0.0034997421,0.227485,0.0016123166,0.00025988085,0.00003364357,0.012548151,0.00012379141,0.68241847,0.00023568395,0.00416191,0.033780854],"study_design_scores_gemma":[0.029405328,0.010705825,0.7749901,0.0012652545,0.00030072473,0.000042510022,0.01287746,0.0032559156,0.14017671,0.00022908326,0.026093522,0.00065759313],"about_ca_topic_score_codex":0.0019891593,"about_ca_topic_score_gemma":0.0010020919,"teacher_disagreement_score":0.5475051,"about_ca_system_score_codex":0.0004531253,"about_ca_system_score_gemma":0.00030436376,"threshold_uncertainty_score":0.33319688},"labels":[],"label_agreement":null},{"id":"W4220854540","doi":"10.1158/2767-9764.crc-21-0119","title":"A Genome-Wide Gene-Based Gene–Environment Interaction Study of Breast Cancer in More than 90,000 Women","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Queen's University; Centre hospitalier universitaire de Québec; Canadian Centre for Applied Research in Cancer Control","funders":"National Institute of Environmental Health Sciences; Cancer Research UK; National Institutes of Health; National Cancer Institute; Medical Research Council; National Health and Medical Research Council","keywords":"Genome-wide association study; Breast cancer; Bonferroni correction; Heritability; Biology; Genetic association; Gene–environment interaction; Genetics; Gene; Genotype; Transcriptome; Missing heritability problem; Expression quantitative trait loci; Gene interaction; Population; Cancer; Gene expression; Oncology; Single-nucleotide polymorphism; Medicine","score_opus":0.0649796946101617,"score_gpt":0.3962778853050389,"score_spread":0.3312981906948772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220854540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994055,0.0016862402,0.00006188403,0.003000845,0.000042875898,0.00061262865,0.00042909692,0.0000049329515,0.00010654918],"genre_scores_gemma":[0.9920787,0.002344337,0.00020255568,0.00013117689,0.00003868219,0.0047540898,0.00018582112,0.000021872043,0.00024275912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743456,0.0012284666,0.00035050866,0.00031628512,0.00029132396,0.00037885868],"domain_scores_gemma":[0.9981473,0.00011616254,0.00014703274,0.0013700059,0.0001362471,0.00008322049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001288174,0.000106665495,0.00019041669,0.00018890949,0.00041152895,0.000010042152,0.0009215488,0.000057123543,0.00039847012],"category_scores_gemma":[0.000067373214,0.000117236894,0.000049222956,0.00034201215,0.00017262442,0.0000043690134,0.0010587046,0.00040580347,0.0000025173356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002255526,0.0016364016,0.77189654,0.0000134109705,0.00018543596,0.000001338565,0.0031356462,0.09563492,0.124266,0.000005851099,0.00045934477,0.0025395644],"study_design_scores_gemma":[0.0009505342,0.0003937695,0.9738765,0.000006735626,0.000012248979,0.0000020707562,0.0082333,0.0012854119,0.0009460971,0.00003928258,0.014105062,0.00014901147],"about_ca_topic_score_codex":0.0037907455,"about_ca_topic_score_gemma":0.0024372356,"teacher_disagreement_score":0.20197994,"about_ca_system_score_codex":0.0008093395,"about_ca_system_score_gemma":0.00033949627,"threshold_uncertainty_score":0.57304984},"labels":[],"label_agreement":null},{"id":"W4224857498","doi":"10.1158/2767-9764.crc-22-0037","title":"Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Government of Ontario","keywords":"Hydroxychloroquine; Repurposing; Itraconazole; Drug repositioning; Ovarian cancer; Cancer; Homeostasis; Medicine; Cancer research; Internal medicine; Pharmacology; Biology; Drug; Coronavirus disease 2019 (COVID-19); Dermatology; Disease; Antifungal","score_opus":0.05911338055807427,"score_gpt":0.4076690462993662,"score_spread":0.34855566574129193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224857498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.949005,0.0333607,0.00003778599,0.014734594,0.00008915725,0.0007864566,0.00057319604,0.00001562456,0.0013974935],"genre_scores_gemma":[0.9890402,0.004630451,0.0010747887,0.00027233647,0.00014158805,0.0030894107,0.00015858919,0.00004202999,0.0015506217],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973389,0.0008315154,0.00026698186,0.00046271418,0.00053419697,0.0005656796],"domain_scores_gemma":[0.9979748,0.000081484286,0.000041549738,0.0014701886,0.00023572544,0.00019625301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015032758,0.00012428469,0.0001624058,0.00036685966,0.0009904337,0.000055713244,0.0011248202,0.00006704613,0.00028284427],"category_scores_gemma":[0.00026646192,0.00014753849,0.00004555367,0.00088896346,0.00034283852,0.000011101865,0.0027560876,0.00079321774,0.000009645342],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032061344,0.00027737374,0.002634005,0.000027395015,0.000056309123,0.000017983219,0.0013793563,0.00133174,0.9578216,0.00045679035,0.011017436,0.024659403],"study_design_scores_gemma":[0.00089662365,0.00027942692,0.0021108044,0.000043153894,0.0000055415317,0.000021934746,0.00074429787,0.00072532083,0.0940522,0.0001259815,0.90072393,0.00027077622],"about_ca_topic_score_codex":0.0037956336,"about_ca_topic_score_gemma":0.0041351877,"teacher_disagreement_score":0.8897065,"about_ca_system_score_codex":0.00047230086,"about_ca_system_score_gemma":0.0007171211,"threshold_uncertainty_score":0.76177156},"labels":[],"label_agreement":null},{"id":"W4225528851","doi":"10.1158/2767-9764.crc-21-0106","title":"Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics","year":2021,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"Basic Research Laboratory; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"PLK1; Cancer research; Biology; Cancer; Triple-negative breast cancer; Kinase; Gene knockdown; Carboplatin; Breast cancer; Cell cycle; Cell biology; Genetics; Chemotherapy; Cell culture; Cisplatin","score_opus":0.08573933261142894,"score_gpt":0.4397340534195935,"score_spread":0.3539947208081645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225528851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9336602,0.0084338505,0.00031088942,0.051387288,0.00013998045,0.002230321,0.0032987664,0.000019169293,0.0005195272],"genre_scores_gemma":[0.9817041,0.0063876724,0.0019811084,0.0018306081,0.000068041394,0.004191572,0.00024561834,0.00005226496,0.0035390083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777085,0.0008380316,0.0002817814,0.00043797088,0.00016135135,0.0005100482],"domain_scores_gemma":[0.9966412,0.00033548454,0.00006008482,0.0017447466,0.0010656804,0.00015279437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009533074,0.00016000353,0.00019460062,0.00014658393,0.00029499762,0.00007711824,0.0009965969,0.00013097377,0.00009086202],"category_scores_gemma":[0.00047379863,0.00016434658,0.00010445308,0.000602248,0.00022202027,0.000010417529,0.00083562057,0.0003209167,0.00000794965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002274554,0.000210076,0.0003909352,0.000028173408,0.0001355462,0.0000017507397,0.0004365896,0.000014818666,0.9882068,0.00009758989,0.003588366,0.0046147844],"study_design_scores_gemma":[0.003992112,0.00035768942,0.023768337,0.00029032005,0.00005047442,0.000035615652,0.0017386893,0.00247584,0.58044153,0.00047322916,0.38580483,0.00057131564],"about_ca_topic_score_codex":0.001443222,"about_ca_topic_score_gemma":0.014557898,"teacher_disagreement_score":0.40776527,"about_ca_system_score_codex":0.0002425103,"about_ca_system_score_gemma":0.0016387438,"threshold_uncertainty_score":0.8123649},"labels":[],"label_agreement":null},{"id":"W4281287807","doi":"10.1158/2767-9764.crc-22-0017","title":"The Tumor Immune Profile of Murine Ovarian Cancer Models: An Essential Tool for Ovarian Cancer Immunotherapy Research","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; National Institutes of Health; Fonds de recherche du Québec; Government of Canada","keywords":"KRAS; Ovarian cancer; PTEN; Immunotherapy; Immune system; Cancer research; Cancer; Biology; Tumor microenvironment; Medicine; Immunology; Colorectal cancer; Internal medicine; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.13927708703653421,"score_gpt":0.44566487634236845,"score_spread":0.3063877893058342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281287807","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2118324,0.69848955,0.0008313209,0.053061463,0.0059964275,0.016037006,0.007198172,0.0005182106,0.006035437],"genre_scores_gemma":[0.9022538,0.034639463,0.0006660713,0.00015139462,0.00019922681,0.049636997,0.00044532926,0.00020612688,0.011801584],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99112725,0.004957603,0.0009886635,0.00071022136,0.0006158086,0.0016004689],"domain_scores_gemma":[0.98951936,0.0024338965,0.00035602093,0.005160177,0.0024658253,0.0000647188],"candidate_categories":["metaepi_narrow","sts","open_science","research_integrity","insufficient_payload"],"consensus_categories":["sts"],"category_scores_codex":[0.00874937,0.00031070196,0.00053915556,0.0004937066,0.007110889,0.00012883084,0.006623458,0.00018157181,0.0038168267],"category_scores_gemma":[0.00026707887,0.00027621424,0.00024215296,0.0016827324,0.0032466326,0.00035079021,0.0031187646,0.0032346565,0.000021331276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004417058,0.0013818498,0.00034922326,0.0001828682,0.0014502401,0.0000023582584,0.007067953,0.0024089229,0.80738705,0.06489886,0.041782312,0.068671286],"study_design_scores_gemma":[0.0048034373,0.00066749554,0.0011722731,0.00018066922,0.00006750272,0.0000145765025,0.0047132424,0.0027088341,0.10419707,0.007670354,0.87324196,0.0005625652],"about_ca_topic_score_codex":0.03065841,"about_ca_topic_score_gemma":0.0036635748,"teacher_disagreement_score":0.83145964,"about_ca_system_score_codex":0.0015754839,"about_ca_system_score_gemma":0.0038955861,"threshold_uncertainty_score":0.999969},"labels":[],"label_agreement":null},{"id":"W4281487088","doi":"10.1158/2767-9764.crc-21-0117","title":"Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy–induced Metastasis","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Mitacs; Government of Canada","keywords":"Ezrin; Chemotherapy; Medicine; Oncology; Metastasis; Breast cancer; Cancer; Internal medicine; Cancer research; Biology; Cell","score_opus":0.1547259839956406,"score_gpt":0.4144323019132961,"score_spread":0.2597063179176555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281487088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88809824,0.009169376,0.0000039087186,0.0999907,0.000050451494,0.0020498922,0.0004556592,0.00004797173,0.00013382704],"genre_scores_gemma":[0.98815,0.0045591816,0.0012308809,0.0011577795,0.000080410675,0.004301601,0.00002100994,0.000055797,0.00044331318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99665177,0.0014058985,0.00032656992,0.00037393137,0.0007753689,0.00046646755],"domain_scores_gemma":[0.9973755,0.00050231064,0.00009900619,0.0014100862,0.00037957847,0.00023353683],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0016402805,0.00018102097,0.000330266,0.00020968795,0.0018048055,0.000119998396,0.0007336126,0.000021309968,0.00050944905],"category_scores_gemma":[0.000087768625,0.00013004926,0.00008597155,0.00093992497,0.000292033,0.00009079328,0.0007858784,0.000824668,0.000006202458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033760845,0.00021363253,0.00007269925,0.000028728222,0.00018415655,0.000012606526,0.0015761005,0.000036294434,0.9574024,0.00020007676,0.0078500435,0.03208565],"study_design_scores_gemma":[0.003109749,0.0011764282,0.0048464234,0.00039030865,0.00014392714,0.00026418339,0.015514606,0.0018233006,0.7929662,0.00019384208,0.17895897,0.0006120839],"about_ca_topic_score_codex":0.0025125672,"about_ca_topic_score_gemma":0.00008158782,"teacher_disagreement_score":0.17110893,"about_ca_system_score_codex":0.00024403955,"about_ca_system_score_gemma":0.00056467607,"threshold_uncertainty_score":0.99949473},"labels":[],"label_agreement":null},{"id":"W4283361673","doi":"10.1158/2767-9764.crc-22-0082","title":"Prospective Associations of Hemoglobin A1c and c-peptide with Risk of Diabetes-related Cancers in the Cancer Prevention Study-II Nutrition Cohort","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Centers for Disease Control and Prevention; World Health Organization; National Institutes of Health; American Cancer Society","keywords":"Medicine; Internal medicine; Prospective cohort study; Cancer; Cohort; Diabetes mellitus; Colorectal cancer; Type 2 diabetes; Pancreatic cancer; Glycemic; Bladder cancer; Proportional hazards model; Oncology; Gastroenterology; Endocrinology; Insulin","score_opus":0.03793149222811286,"score_gpt":0.373782255448416,"score_spread":0.3358507632203031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283361673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90180486,0.09552923,0.0000029646105,0.00021382324,0.000026923926,0.0016230664,0.0004919811,0.000003912787,0.00030323293],"genre_scores_gemma":[0.93940103,0.053879827,0.00006231699,0.000025545929,0.000023581519,0.0063751577,0.00012972554,0.000014190829,0.000088639616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997352,0.0014096528,0.00029675572,0.000262081,0.00045031475,0.00022920138],"domain_scores_gemma":[0.9982786,0.00010950747,0.00023538547,0.0009227767,0.00041874466,0.00003499243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020696146,0.00009481057,0.00020542183,0.00012077595,0.00059149327,0.000012941286,0.00068221876,0.000044556153,0.000048675513],"category_scores_gemma":[0.00011226714,0.00008084857,0.00004814593,0.00081249984,0.00035019897,0.0000122277925,0.00045476953,0.00045258494,1.3119617e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008055482,0.0010259907,0.98013365,0.00004083963,0.00049122336,1.4055492e-7,0.0030773275,0.0009681973,0.0055991374,0.00025904886,0.0012780066,0.0070458623],"study_design_scores_gemma":[0.0033009013,0.0015651565,0.9596094,0.00012865909,0.00024219367,5.2900265e-7,0.010030512,0.00032969733,0.0077485205,0.0014354641,0.01536768,0.0002413139],"about_ca_topic_score_codex":0.004193114,"about_ca_topic_score_gemma":0.015063383,"teacher_disagreement_score":0.0416494,"about_ca_system_score_codex":0.00030798712,"about_ca_system_score_gemma":0.00058812107,"threshold_uncertainty_score":0.8405721},"labels":[],"label_agreement":null},{"id":"W4292185501","doi":"10.1158/2767-9764.crc-21-0135","title":"Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; Physicians' Services Incorporated Foundation; National Institute of Dental and Craniofacial Research; Free To Breathe; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; North Carolina Biotechnology Center; Lung Cancer Research Foundation; National Cancer Institute; National Institutes of Health; Yale University","keywords":"Immunohistochemistry; Tissue microarray; Head and neck squamous-cell carcinoma; Immunostaining; Medicine; Cancer; Head and neck cancer; Cancer research; Pathology; Oncology; Immune system; HPV infection; Biomarker; Biology; Internal medicine; Cervical cancer; Immunology","score_opus":0.13157024526347763,"score_gpt":0.4713348231637256,"score_spread":0.33976457790024794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292185501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8600319,0.118025735,0.0000015064145,0.017441379,0.00004623962,0.002082133,0.000093855444,0.000044997716,0.0022322303],"genre_scores_gemma":[0.9431035,0.04359208,0.00021600678,0.00024846647,0.00002920578,0.011938638,0.000021131249,0.00004059045,0.0008104103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967718,0.0008907705,0.00030886027,0.0004946439,0.00086143444,0.0006724972],"domain_scores_gemma":[0.99501026,0.0030325935,0.00006482762,0.0012719714,0.00030422115,0.0003161489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011758915,0.00017556167,0.00033494132,0.00055749156,0.0010937606,0.000060849587,0.00059706386,0.000040014762,0.00046413267],"category_scores_gemma":[0.0022452387,0.00016469185,0.000037394228,0.0011904514,0.00092966645,0.0001306649,0.0035632318,0.0013844246,0.000010244963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010584163,0.0014491124,0.9028795,0.0012206265,0.00017024892,0.0002766438,0.005631291,0.000036302154,0.032883324,0.00065925956,0.018420579,0.0353147],"study_design_scores_gemma":[0.0042819353,0.0009091194,0.8907805,0.0019366739,0.00006919602,0.00008419301,0.0038991347,0.0011246958,0.0011437489,0.00063767977,0.09476171,0.00037142754],"about_ca_topic_score_codex":0.007841412,"about_ca_topic_score_gemma":0.002911479,"teacher_disagreement_score":0.083071545,"about_ca_system_score_codex":0.0009884516,"about_ca_system_score_gemma":0.0011110475,"threshold_uncertainty_score":0.99876547},"labels":[],"label_agreement":null},{"id":"W4293244159","doi":"10.1158/2767-9764.crc-22-0083","title":"Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"ZonMw; Auris Health","keywords":"Chronic lymphocytic leukemia; B cell; Cancer research; Cell culture; T cell; CD19; Antigen; Antibody; Medicine; Leukemia; Immunology; Biology; Immune system","score_opus":0.1152114811457825,"score_gpt":0.40627376921070274,"score_spread":0.29106228806492024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293244159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9478111,0.023041159,0.000003913024,0.0023575197,0.000045137687,0.00086956477,0.00010436872,0.00006486588,0.025702365],"genre_scores_gemma":[0.9756541,0.016496684,0.00028836945,0.00012908706,0.00010531335,0.0005941998,0.000032960943,0.0000643136,0.0066349297],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99623114,0.0008864299,0.00032096298,0.00055340596,0.001118936,0.0008891331],"domain_scores_gemma":[0.99691254,0.00089585374,0.00010406743,0.0015529617,0.00027067657,0.00026390696],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0016038077,0.00023842104,0.00046573483,0.00065673364,0.0016510144,0.00009081682,0.0009164134,0.00007549898,0.0004491276],"category_scores_gemma":[0.00007617364,0.00020937558,0.00007946646,0.001558354,0.0011106215,0.00014458658,0.0017325855,0.0015477483,0.000030792267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.002850407,0.0016582428,0.35902995,0.0024681955,0.00041649057,0.00044188733,0.007877821,0.0026698587,0.572883,0.0019279721,0.011244167,0.036532033],"study_design_scores_gemma":[0.015860027,0.002295503,0.1820283,0.0013255044,0.00013453164,0.0004903326,0.007638367,0.047606837,0.06955154,0.00031310853,0.6713585,0.0013974549],"about_ca_topic_score_codex":0.021160278,"about_ca_topic_score_gemma":0.0026770213,"teacher_disagreement_score":0.66011435,"about_ca_system_score_codex":0.008630629,"about_ca_system_score_gemma":0.006804486,"threshold_uncertainty_score":0.9996487},"labels":[],"label_agreement":null},{"id":"W4295280957","doi":"10.1158/2767-9764.crc-22-0190","title":"Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis","year":2022,"lang":"en","type":"review","venue":"Cancer Research Communications","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Meath Foundation","keywords":"Meta-analysis; Pancreatic cancer; Medicine; Systematic review; Internal medicine; Oncology; Cancer; MEDLINE; Biology","score_opus":0.5081880451646883,"score_gpt":0.5801279835435706,"score_spread":0.07193993837888235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295280957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019565102,0.9752858,0.00002893174,0.003617226,0.000011121348,0.018777834,0.0019633828,0.000027896434,0.00028583445],"genre_scores_gemma":[0.000027171556,0.87181056,0.0009335603,0.00021248106,0.000014938438,0.12534077,0.0007105219,0.000067585745,0.00088241085],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99133,0.004518693,0.0018185417,0.0006303115,0.0010640105,0.0006384102],"domain_scores_gemma":[0.9469617,0.04589253,0.0010095224,0.00480105,0.0010273155,0.00030790202],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0067174146,0.00044540406,0.011649942,0.0013531413,0.00064881967,0.00003878433,0.0018840511,0.00021316006,0.002558046],"category_scores_gemma":[0.01961687,0.0003144409,0.0026014925,0.00405205,0.0010505927,0.00005768995,0.0008189156,0.0012091635,0.0000063953125],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011914088,0.00025253027,0.00004468778,0.73218167,0.26338556,0.000004348119,0.000034471203,3.7728014e-7,2.0880755e-7,0.00011548389,0.001198308,0.0027704355],"study_design_scores_gemma":[0.00033873058,0.00018384322,0.000004958028,0.05284447,0.78712565,0.000011108993,0.00004383594,0.00010642707,2.7544945e-7,0.000020122043,0.15913568,0.00018490519],"about_ca_topic_score_codex":0.0018953995,"about_ca_topic_score_gemma":0.00043459493,"teacher_disagreement_score":0.6793372,"about_ca_system_score_codex":0.00058033236,"about_ca_system_score_gemma":0.0048493664,"threshold_uncertainty_score":0.99993074},"labels":[],"label_agreement":null},{"id":"W4307638653","doi":"10.1158/2767-9764.crc-22-0240","title":"<i>Ad hoc</i> Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline <i>BRCA</i> Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Homologous recombination; Germline; Ovarian cancer; Medicine; Oncology; Biology; Cancer; Genetics; Internal medicine; DNA; Gene","score_opus":0.15425510176700669,"score_gpt":0.47739420077474237,"score_spread":0.3231390990077357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307638653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97091615,0.014376468,0.00002314734,0.009654488,0.0002631189,0.0033168246,0.00021321788,0.00010181775,0.0011347674],"genre_scores_gemma":[0.98809993,0.0069848667,0.00019033064,0.00040352615,0.000042590338,0.003622639,0.0002434899,0.000050168343,0.00036244575],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941775,0.0024877167,0.00079347723,0.00059521827,0.0014120557,0.000534001],"domain_scores_gemma":[0.9937783,0.00069574,0.00034552527,0.0038403666,0.0011775307,0.0001625403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030482789,0.00023899013,0.0006962509,0.001168995,0.0009741763,0.000029862947,0.0014094048,0.0000773451,0.00084589474],"category_scores_gemma":[0.0002606572,0.00019927527,0.00025271633,0.011409002,0.0005870605,0.00012003564,0.000852023,0.0019431445,0.000002907127],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052597657,0.117359295,0.3145347,0.0006304478,0.026335469,0.00019724318,0.08757466,0.05601785,0.036528602,0.0048736488,0.05417203,0.2491784],"study_design_scores_gemma":[0.1802712,0.025964191,0.28754672,0.0027799278,0.010640393,0.00008962051,0.020542141,0.06195235,0.005267895,0.0009875488,0.40113777,0.0028202431],"about_ca_topic_score_codex":0.0045169704,"about_ca_topic_score_gemma":0.021518162,"teacher_disagreement_score":0.34696573,"about_ca_system_score_codex":0.0022723216,"about_ca_system_score_gemma":0.0019034265,"threshold_uncertainty_score":0.9963366},"labels":[],"label_agreement":null},{"id":"W4312070075","doi":"10.1158/2767-9764.crc-22-0410","title":"Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992–2019","year":2022,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Center for Research Resources; National Cancer Institute; Rogel Cancer Center, University of Michigan","keywords":"Pacific islanders; Incidence (geometry); Medicine; Ovarian cancer; Demography; Epidemiology; Ethnic group; Serous fluid; Confidence interval; Cancer; Gynecology; Oncology; Internal medicine; Population; Environmental health","score_opus":0.1301284505922743,"score_gpt":0.45416079050489827,"score_spread":0.324032339912624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312070075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6447507,0.09495132,0.000010245745,0.25545406,0.000070400056,0.0010500334,0.0011984289,0.000028140968,0.0024866536],"genre_scores_gemma":[0.94802475,0.048297457,0.00011305038,0.0006658917,0.000015471218,0.00192157,0.0003363761,0.0000147558,0.0006106565],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978801,0.0008450823,0.0002472775,0.00021197528,0.00055596366,0.0002596228],"domain_scores_gemma":[0.9975715,0.00074103626,0.00008177951,0.0013352197,0.00018693568,0.00008348172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013014368,0.00009328502,0.00021124103,0.0003795194,0.00048171036,0.000019282697,0.0006878676,0.000030847492,0.0006066374],"category_scores_gemma":[0.00007647499,0.00007341604,0.000038848884,0.001971095,0.00045949922,0.000054300424,0.0005030426,0.0007518603,0.0000014016664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097354065,0.003935843,0.44681278,0.0002310192,0.00054829364,0.000034574943,0.03234438,0.0009105873,0.0027836135,0.012409656,0.38916606,0.10984968],"study_design_scores_gemma":[0.0022916647,0.00053279864,0.30160943,0.00018479227,0.000099214914,0.000010383235,0.0029425414,0.0014993413,0.00028049597,0.0004968873,0.68989897,0.00015348395],"about_ca_topic_score_codex":0.11678311,"about_ca_topic_score_gemma":0.009633819,"teacher_disagreement_score":0.30327404,"about_ca_system_score_codex":0.0008351509,"about_ca_system_score_gemma":0.00044794945,"threshold_uncertainty_score":0.8890983},"labels":[],"label_agreement":null},{"id":"W4318483914","doi":"10.1158/2767-9764.crc-22-0456","title":"Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Ontario Institute for Cancer Research; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Government of Ontario; Princess Margaret Cancer Foundation","keywords":"Epigenomics; Melanoma; DNA sequencing; Cell-free fetal DNA; CDKN2A; Oncology; Computational biology; Medicine; Biology; Cancer research; Internal medicine; DNA; Cancer; Gene; DNA methylation; Genetics","score_opus":0.09865593293251709,"score_gpt":0.4082315612715743,"score_spread":0.30957562833905716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318483914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99090034,0.003191519,0.00006855826,0.0013396293,0.000038720984,0.00017866399,0.0004513567,0.000008747576,0.0038224452],"genre_scores_gemma":[0.9831568,0.015279688,0.0003231668,0.000023797824,0.000031116273,0.00019584264,0.0005827943,0.000013116969,0.00039366848],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989337,0.00016337428,0.00022683114,0.00021475666,0.00019274524,0.00026860714],"domain_scores_gemma":[0.9973978,0.00019322133,0.000049499486,0.0019791545,0.0003101087,0.00007021085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066775293,0.00007434083,0.00016211321,0.00053798547,0.00011123061,0.000021582084,0.001279558,0.0000773636,0.00004654994],"category_scores_gemma":[0.0003286556,0.00007822626,0.000092268725,0.0024333294,0.000268004,0.0000030081208,0.0011017581,0.00022057563,0.0000105498975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002170332,0.0005124593,0.30998847,0.0000753641,0.0010144626,0.00000946106,0.0008046881,0.0046856073,0.6181938,0.0045583276,0.05191147,0.00802887],"study_design_scores_gemma":[0.0026639902,0.0006306859,0.5505744,0.00012417442,0.00043808948,0.0000018279295,0.0026719167,0.0146672195,0.17281546,0.0019736951,0.25273052,0.00070799177],"about_ca_topic_score_codex":0.002565559,"about_ca_topic_score_gemma":0.025526268,"teacher_disagreement_score":0.44537833,"about_ca_system_score_codex":0.000089656125,"about_ca_system_score_gemma":0.00038814335,"threshold_uncertainty_score":0.99225533},"labels":[],"label_agreement":null},{"id":"W4320915582","doi":"10.1158/2767-9764.crc-22-0278","title":"Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and Signaling","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Canada's Michael Smith Genome Sciences Centre; iCo Therapeutics (Canada); University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Government of Canada","keywords":"Immune system; Cancer research; Immunotherapy; Medicine; Myeloid; Tumor microenvironment; Cancer immunotherapy; Immunology; T cell; Adoptive cell transfer; Myeloid-derived Suppressor Cell; Dendritic cell; Immune tolerance; Progenitor cell; Cancer; Biology; Stem cell; Suppressor; Cell biology; Internal medicine","score_opus":0.07868338862103307,"score_gpt":0.3562744120607587,"score_spread":0.27759102343972564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320915582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94664174,0.05126177,0.000035122805,0.0007309133,0.00012948718,0.0005912,0.00009988586,0.0001580056,0.00035184724],"genre_scores_gemma":[0.995184,0.003771626,0.000050890718,0.000021433505,0.000018300449,0.0004020203,0.00029266046,0.000025858253,0.00023318175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977371,0.0010859572,0.00037074767,0.00028358176,0.00009436452,0.00042825888],"domain_scores_gemma":[0.99807864,0.0005543171,0.00013082824,0.0009400589,0.00024793195,0.000048213584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012334823,0.00014370352,0.00028321214,0.00031701342,0.0012654567,0.00008162374,0.00052614714,0.00008344852,0.0000307359],"category_scores_gemma":[0.000036016932,0.00014191733,0.00004637295,0.0005081755,0.0006301904,0.00016738444,0.00061824993,0.00048767295,0.00012008327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046014397,0.00003079695,0.0005133585,0.00021245728,0.000059928258,0.0000019524773,0.00070963165,0.000027407308,0.99614906,0.0010917551,0.0005382865,0.0006193466],"study_design_scores_gemma":[0.0027612173,0.00017830054,0.02805838,0.0018111833,0.000097289376,0.00025887313,0.010410053,0.0025012481,0.9467848,0.00012346767,0.006517812,0.00049737346],"about_ca_topic_score_codex":0.0006470949,"about_ca_topic_score_gemma":0.000025166464,"teacher_disagreement_score":0.049364265,"about_ca_system_score_codex":0.00021711654,"about_ca_system_score_gemma":0.00012610806,"threshold_uncertainty_score":0.9732998},"labels":[],"label_agreement":null},{"id":"W4323353330","doi":"10.1158/2767-9764.crc-22-0385","title":"Treatment Patterns and Outcomes of Preoperative Neoadjuvant Radiotherapy in Patients with Early-onset Rectal Cancer","year":2023,"lang":"en","type":"review","venue":"Cancer Research Communications","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; Spinal Cord Injury BC; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Foundation; Michael Smith Health Research BC","keywords":"Medicine; Colorectal cancer; Radiation therapy; Chemoradiotherapy; Internal medicine; Stage (stratigraphy); Multivariate analysis; Confidence interval; Oncology; Cancer; Young adult; Surgery","score_opus":0.21903878581119057,"score_gpt":0.5103444049152507,"score_spread":0.2913056191040601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323353330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10512711,0.88797355,4.7555966e-7,0.00044294837,0.0000454133,0.0046629617,0.0015620856,0.000036239202,0.0001492328],"genre_scores_gemma":[0.02127632,0.9684735,0.00010346112,0.000010507169,0.000024807265,0.008896428,0.0003383973,0.000101881575,0.0007747012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690586,0.00083692657,0.0006168116,0.0005216856,0.0006427558,0.0004759542],"domain_scores_gemma":[0.9962695,0.001208444,0.00021298692,0.0016814445,0.00040709635,0.00022050051],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027992454,0.00041300472,0.0019730565,0.00059062993,0.00016411803,0.000034910194,0.00051222416,0.00018183119,0.00011598664],"category_scores_gemma":[0.00008568339,0.00026193768,0.00020483426,0.0011655231,0.00049214513,0.00008249449,0.00034492658,0.0007436069,0.000007807636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023348149,0.00060164795,0.57294255,0.0014935477,0.001314206,0.000011502884,0.00073606375,5.929374e-7,5.5449398e-8,0.000010015306,0.00003442257,0.42262194],"study_design_scores_gemma":[0.004886032,0.0025205798,0.8443818,0.018836156,0.0006433805,0.0000044162407,0.00007081961,0.000011721811,0.0000023168948,0.000008037897,0.12829086,0.00034385055],"about_ca_topic_score_codex":0.014564302,"about_ca_topic_score_gemma":0.01029775,"teacher_disagreement_score":0.42227808,"about_ca_system_score_codex":0.0028392463,"about_ca_system_score_gemma":0.001498362,"threshold_uncertainty_score":0.9999833},"labels":[],"label_agreement":null},{"id":"W4361269370","doi":"10.1158/2767-9764.crc-22-0403","title":"CD142 Identifies Neoplastic Desmoid Tumor Cells, Uncovering Interactions Between Neoplastic and Stromal Cells That Drive Proliferation","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Hospital for Sick Children; Desmoid Tumor Research Foundation","keywords":"Stromal cell; Cancer research; Tumor cells; Biology; Cell biology; Pathology; Medicine","score_opus":0.16229349146834116,"score_gpt":0.433191921041039,"score_spread":0.27089842957269783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361269370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99292,0.0011628495,0.00011357398,0.0034618564,0.00029249358,0.00095982535,0.0002423502,0.0002532296,0.0005938618],"genre_scores_gemma":[0.9942996,0.002248311,0.00044373714,0.000039601782,0.00023330528,0.0008667068,0.0001706649,0.000048658392,0.0016494307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787146,0.00030402344,0.00032450262,0.00036758,0.0005996792,0.00053273136],"domain_scores_gemma":[0.9955428,0.0024914942,0.000091994014,0.0011364601,0.0004976846,0.00023953294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005880551,0.00018989561,0.00033117534,0.000526553,0.0011993096,0.00016315797,0.00034568176,0.0000456843,0.0000844077],"category_scores_gemma":[0.0007078063,0.00019088315,0.00006447995,0.0010338183,0.00066799787,0.00028662273,0.0010088644,0.00089317653,0.00028304377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006175093,0.0006959237,0.5039227,0.002316375,0.002010725,0.0005121343,0.026882589,0.0012777951,0.35464033,0.0016070504,0.09813575,0.0073811063],"study_design_scores_gemma":[0.0040381323,0.0010571112,0.7442637,0.0031713457,0.0009924731,0.00019675346,0.022603976,0.009389283,0.14917383,0.0021248588,0.061810773,0.0011777448],"about_ca_topic_score_codex":0.00043456806,"about_ca_topic_score_gemma":0.001182039,"teacher_disagreement_score":0.240341,"about_ca_system_score_codex":0.00038664823,"about_ca_system_score_gemma":0.00038732364,"threshold_uncertainty_score":0.92242414},"labels":[],"label_agreement":null},{"id":"W4362577044","doi":"10.1158/2767-9764.crc-22-0402","title":"Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Mount Sinai Hospital; McMaster University; London Health Sciences Centre; Western University; Ontario Brain Institute; Vector Institute; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Government of Canada; Robert Connor Dawes Foundation; Hospital for Sick Children; Terry Fox Research Institute; Garron Family Cancer Centre","keywords":"Penetrance; Li–Fraumeni syndrome; Germline; Cancer; Genetics; Biology; Epigenetics; Germline mutation; Breast cancer; Genetic testing; Bioinformatics; Oncology; Gene; Medicine; Phenotype; Mutation","score_opus":0.09316922365304761,"score_gpt":0.4119469256300037,"score_spread":0.3187777019769561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362577044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844903,0.0013771809,0.00008523151,0.010587523,0.00009961596,0.0026992282,0.00021681214,0.0001331732,0.0003109572],"genre_scores_gemma":[0.9911841,0.0011908604,0.0010468916,0.00026081846,0.000023312277,0.0044231787,0.0005010079,0.00006654736,0.0013032564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997162,0.00023662446,0.0004067095,0.00040457194,0.0010172011,0.0007728809],"domain_scores_gemma":[0.99651617,0.0002497313,0.00006612128,0.001799103,0.0009771581,0.0003917023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008656022,0.00017969463,0.00033697605,0.000762934,0.00035725397,0.00002503187,0.0007811453,0.00010380091,0.00013636591],"category_scores_gemma":[0.00044509032,0.00016723263,0.000045298675,0.0029820781,0.00014813057,0.00008905503,0.00082438166,0.00085790886,0.00029894142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018683769,0.001818874,0.9206081,0.0003021021,0.00076137943,0.00011249045,0.0043686256,0.0025141884,0.0045796447,0.00021110104,0.017597979,0.045257147],"study_design_scores_gemma":[0.005524924,0.00027584433,0.84832793,0.0013259299,0.000026017322,0.0000031143238,0.000096669704,0.0005349082,0.0010204152,0.000023197272,0.14259331,0.00024772293],"about_ca_topic_score_codex":0.0016576789,"about_ca_topic_score_gemma":0.008099598,"teacher_disagreement_score":0.124995336,"about_ca_system_score_codex":0.0020391752,"about_ca_system_score_gemma":0.0015573357,"threshold_uncertainty_score":0.6819549},"labels":[],"label_agreement":null},{"id":"W4376956889","doi":"10.1158/2767-9764.crc-23-0010","title":"Targeting CHAF1B Enhances IFN Activity against Myeloproliferative Neoplasm Cells","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Cancer Institute; National Institutes of Health; MPN Research Foundation; Northwestern University; National Institute of General Medical Sciences; Robert H. Lurie Comprehensive Cancer Center; Weinberg College of Arts and Sciences, Northwestern University; U.S. Department of Veterans Affairs","keywords":"Myeloproliferative neoplasm; Neoplasm; Cancer research; Myeloproliferative Disorders; Immunology; Medicine; Myelofibrosis; Bone marrow; Pathology","score_opus":0.16180218825012613,"score_gpt":0.4612231435675354,"score_spread":0.2994209553174093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376956889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.930618,0.0029715206,0.000059911712,0.03715751,0.00022856188,0.0023472502,0.00019537564,0.00036468287,0.026057174],"genre_scores_gemma":[0.95532686,0.035284683,0.00089855725,0.00026060425,0.0002090431,0.0036544888,0.00020282126,0.000048247515,0.0041147172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969416,0.00067437,0.0003281644,0.0004816104,0.0008044777,0.0007697441],"domain_scores_gemma":[0.9956751,0.0013851206,0.00010329704,0.0016119668,0.0008885763,0.00033596903],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012058298,0.00024032753,0.0004209678,0.00041545677,0.0015249863,0.000108212196,0.00064484595,0.00011917565,0.00019935313],"category_scores_gemma":[0.00047743178,0.00020628468,0.00012319647,0.0016933663,0.00054719124,0.00021450264,0.00070775696,0.0010122588,0.0008743622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065974647,0.0031363221,0.03653516,0.0005906201,0.0016853013,0.00016580458,0.012632782,0.0006491966,0.6532643,0.0088063115,0.13499159,0.14688288],"study_design_scores_gemma":[0.0037284654,0.0007315038,0.06948252,0.0010951246,0.00013280846,0.000009622066,0.003597599,0.015312495,0.58755004,0.00084732653,0.31670904,0.00080345245],"about_ca_topic_score_codex":0.0003879788,"about_ca_topic_score_gemma":0.00055122183,"teacher_disagreement_score":0.18171744,"about_ca_system_score_codex":0.0005558123,"about_ca_system_score_gemma":0.00084726186,"threshold_uncertainty_score":0.99990356},"labels":[],"label_agreement":null},{"id":"W4378212723","doi":"10.1158/2767-9764.crc-23-0144","title":"Mitochondria Transfer from Mesenchymal Stem Cells Confers Chemoresistance to Glioblastoma Stem Cells through Metabolic Rewiring","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Metabolomics Innovation Centre","funders":"Société d'Accélération du Transfert de Technologies; Région Occitanie Pyrénées-Méditerranée; Institut National Du Cancer; Fondation ARC pour la Recherche sur le Cancer; Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; Ligue Contre le Cancer; Agence Nationale de la Recherche","keywords":"Stem cell; Mesenchymal stem cell; Glioblastoma; Cancer stem cell; Cell biology; Mitochondrion; Cancer research; Biology; Neural stem cell; Chemistry","score_opus":0.08613808428419077,"score_gpt":0.37143782093573,"score_spread":0.28529973665153924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378212723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94209754,0.04525275,0.0010568018,0.0042095473,0.0017924984,0.0016560253,0.0013996251,0.00015765411,0.0023775818],"genre_scores_gemma":[0.9214039,0.063747756,0.0010412656,0.000493139,0.0014739502,0.0017124759,0.0001142842,0.0001305352,0.009882733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99685884,0.0005078004,0.00042076345,0.00073156814,0.00062268873,0.00085834524],"domain_scores_gemma":[0.9958814,0.00017625895,0.00005268404,0.003012586,0.00054450356,0.00033259075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006281685,0.0002772904,0.00038995288,0.00019121093,0.0005876751,0.000132824,0.0020586853,0.00020723653,0.00008563792],"category_scores_gemma":[0.000027635386,0.00029457928,0.0001966156,0.0011988017,0.00041096273,0.000026527845,0.00084365817,0.00054917554,0.00022873213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017149014,0.00005409197,0.000027411537,0.000027148244,0.00014284057,0.0000012476445,0.001151961,0.00018788157,0.9422373,0.00065769255,0.048595108,0.006745831],"study_design_scores_gemma":[0.00041049276,0.00004234383,0.00012906309,0.00004369114,0.00002487388,4.9809626e-7,0.0007007314,0.000053188076,0.5009525,0.000052457915,0.49740034,0.00018986901],"about_ca_topic_score_codex":0.0009958755,"about_ca_topic_score_gemma":0.0032991527,"teacher_disagreement_score":0.4488052,"about_ca_system_score_codex":0.00010127153,"about_ca_system_score_gemma":0.0005817046,"threshold_uncertainty_score":0.99995065},"labels":[],"label_agreement":null},{"id":"W4378233411","doi":"10.1158/2767-9764.crc-23-0003","title":"Antidepressant Use and Lung Cancer Risk and Survival: A Meta-analysis of Observational Studies","year":2023,"lang":"en","type":"review","venue":"Cancer Research Communications","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Central Florida","keywords":"Medicine; Meta-analysis; Lung cancer; Internal medicine; Subgroup analysis; Observational study; Relative risk; Oncology; Cancer; Confidence interval; Cochrane Library","score_opus":0.8016094916276023,"score_gpt":0.6075673273531814,"score_spread":0.1940421642744209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378233411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053264725,0.9945311,0.0000036931458,0.0013115333,0.000050093557,0.0014641236,0.0020303654,0.00004217172,0.0000342497],"genre_scores_gemma":[0.00018057889,0.99396944,0.00017296567,0.000026475045,0.00008166576,0.0033808283,0.00029744965,0.000077371486,0.0018132316],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.99462074,0.0024935787,0.0010102574,0.0005808172,0.0008742024,0.00042038903],"domain_scores_gemma":[0.98433864,0.010493932,0.00056514033,0.0027872424,0.0016300186,0.00018502881],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030037314,0.00037922704,0.004463535,0.0014094699,0.00055987615,0.00009844542,0.00071849173,0.00019734888,0.00010087193],"category_scores_gemma":[0.0026159803,0.0002837748,0.0011543601,0.0033639814,0.0015808212,0.00018037535,0.0011082079,0.0011276148,0.0000021129465],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021435467,0.0002657452,0.015507438,0.03331042,0.78270334,0.000015333719,0.0017767353,0.000035579145,0.0000047406293,0.0010991709,0.008453975,0.15661316],"study_design_scores_gemma":[0.00024816405,0.00003698071,0.0091977,0.0033573583,0.33326548,0.000005022473,0.00027740933,0.00028416098,8.9085063e-7,0.000023018682,0.6530727,0.00023111005],"about_ca_topic_score_codex":0.008326761,"about_ca_topic_score_gemma":0.007036675,"teacher_disagreement_score":0.64461875,"about_ca_system_score_codex":0.00033642646,"about_ca_system_score_gemma":0.0015222181,"threshold_uncertainty_score":0.99996144},"labels":[],"label_agreement":null},{"id":"W4379798163","doi":"10.1158/2767-9764.crc-22-0152","title":"Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sciencetech (Canada); Princess Margaret Cancer Centre; Artificial Intelligence in Medicine (Canada); University of Toronto","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; Canadian HIV Trials Network, Canadian Institutes of Health Research","keywords":"Generalizability theory; Radiomics; Artificial intelligence; Machine learning; Computer science; Deep learning; Artificial neural network; Medicine; Medical physics; Statistics","score_opus":0.22343244065220885,"score_gpt":0.5324583583627135,"score_spread":0.30902591771050464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379798163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725049,0.02258783,0.0006211599,0.0037424131,0.000016890881,0.00043813512,0.000008906733,0.000028362068,0.000051368635],"genre_scores_gemma":[0.95532936,0.035218596,0.009152948,0.000028172517,0.00002808724,0.00017201864,0.00003243719,0.000015289243,0.000023065819],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998503,0.0004018256,0.00027400348,0.00023498847,0.00029882893,0.00028729884],"domain_scores_gemma":[0.9986019,0.00059796,0.000047965284,0.00032683864,0.0002487095,0.00017662301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025524476,0.00009492493,0.00024863897,0.0002856506,0.0004065552,0.000035414232,0.00014848604,0.00005287992,0.000011428635],"category_scores_gemma":[0.0027322243,0.00008207912,0.000026532083,0.00056085945,0.00067059003,0.00008494225,0.00038936504,0.00089216995,4.2122292e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055848788,0.000067556684,0.8251425,0.00027691605,0.00004996106,0.000003149619,0.0018589633,0.03139553,0.009257633,0.00015180235,0.000011156064,0.13172895],"study_design_scores_gemma":[0.0011101078,0.00007188767,0.16253415,0.0003670651,0.000018560635,0.000011021757,0.00023351297,0.83529186,0.000011563046,0.00016575666,0.00012649652,0.00005801205],"about_ca_topic_score_codex":0.004619095,"about_ca_topic_score_gemma":0.00068374013,"teacher_disagreement_score":0.8038963,"about_ca_system_score_codex":0.00021402836,"about_ca_system_score_gemma":0.00038613685,"threshold_uncertainty_score":0.6982721},"labels":[],"label_agreement":null},{"id":"W4383556694","doi":"10.1158/2767-9764.crc-23-0111","title":"Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genentech; Astellas Pharma; Academy of Medical Sciences; China Scholarship Council; National Institute for Health and Care Research; Wilhelm Sander-Stiftung; Medical Research Council; Sanofi; Prostate Cancer UK; Prostate Cancer Foundation","keywords":"Fulvestrant; Estrogen receptor; Cancer research; Breast cancer; Estrogen receptor alpha; Androgen receptor; Imidazopyridine; Prostate cancer; Cancer; Pharmacology; Transactivation; Estrogen; Cell growth; Chemistry; Internal medicine; Biology; Medicine; Biochemistry; Gene expression","score_opus":0.08932779712755888,"score_gpt":0.45344929119679017,"score_spread":0.3641214940692313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383556694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929611,0.0030727228,0.000070718044,0.0022041379,0.000061359075,0.0009398617,0.0005861464,0.00003986268,0.00006408415],"genre_scores_gemma":[0.99011767,0.0062912186,0.00030306057,0.000046309324,0.00009866553,0.0016951096,0.0012336725,0.00004409876,0.00017017456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983711,0.00053663406,0.00023100695,0.00028669208,0.0002401102,0.0003344179],"domain_scores_gemma":[0.997483,0.00012381155,0.000100118414,0.001255352,0.0008936165,0.00014408196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008633248,0.0001237705,0.00014126067,0.00015590075,0.0005267352,0.000048210815,0.0009009717,0.00015871804,0.000023584771],"category_scores_gemma":[0.00008235297,0.00011713103,0.00008616338,0.00063662755,0.00038523553,0.000020229107,0.0001199414,0.0002450071,0.000010940848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046788645,0.00027610082,0.0011586178,0.00002273724,0.00014844362,1.8360117e-7,0.00019918616,0.00041803002,0.9831578,0.0004081934,0.0021054486,0.011637376],"study_design_scores_gemma":[0.0013371642,0.0006719674,0.004038956,0.000041135478,0.000025516596,0.0000038902476,0.00042069677,0.0066885906,0.9778226,0.00034690197,0.008387281,0.0002152741],"about_ca_topic_score_codex":0.00070976594,"about_ca_topic_score_gemma":0.00035419775,"teacher_disagreement_score":0.011422101,"about_ca_system_score_codex":0.0000895053,"about_ca_system_score_gemma":0.00072286645,"threshold_uncertainty_score":0.47764647},"labels":[],"label_agreement":null},{"id":"W4385553990","doi":"10.1158/2767-9764.crc-23-0284","title":"Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Sanofi","keywords":"Medicine; Dosing; Pharmacokinetics; Adverse effect; Internal medicine; Gastroenterology; Surgery","score_opus":0.17965015765821107,"score_gpt":0.5281509426034129,"score_spread":0.3485007849452018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385553990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656296,0.00025938055,0.000041576615,0.0013307123,0.000010175997,0.0014109825,0.0000848369,0.000031508956,0.00026786738],"genre_scores_gemma":[0.9982865,0.0009854932,0.00039217962,0.000016791377,0.000025107905,0.00018714897,0.000043852764,0.000022785427,0.000040184288],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99849695,0.00020633548,0.0002812719,0.00027616209,0.0004345818,0.00030471975],"domain_scores_gemma":[0.9980578,0.00031745646,0.00009948069,0.0008858106,0.00048361075,0.00015588198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046681945,0.000118505486,0.0002907746,0.00023015094,0.00028191603,0.00001740813,0.00031767495,0.000027299313,0.00001846468],"category_scores_gemma":[0.000135439,0.00010892175,0.000019536092,0.0013795978,0.000499235,0.00012916583,0.00032116004,0.0005857785,0.0000015690971],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008258101,0.021096831,0.13899978,0.0006819029,0.00060483476,0.00005439337,0.0063612587,0.0033047684,0.76629394,0.000298885,0.00018644785,0.05385887],"study_design_scores_gemma":[0.09603401,0.0039543537,0.46810558,0.003041588,0.00049095834,0.0000171684,0.0064799534,0.13216539,0.28596377,0.00028264086,0.002555611,0.00090894935],"about_ca_topic_score_codex":0.00022409481,"about_ca_topic_score_gemma":0.00003639277,"teacher_disagreement_score":0.48033014,"about_ca_system_score_codex":0.00023440798,"about_ca_system_score_gemma":0.00018575064,"threshold_uncertainty_score":0.44417},"labels":[],"label_agreement":null},{"id":"W4386878679","doi":"10.1158/2767-9764.crc-23-0084","title":"The Inherited <i>KRAS</i> -variant as a Biomarker of Cetuximab Response in NSCLC","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"University of Texas MD Anderson Cancer Center; National Cancer Institute; NRG Oncology; Eli Lilly and Company","keywords":"Cetuximab; KRAS; Medicine; Internal medicine; Hazard ratio; Oncology; Lung cancer; Proportional hazards model; Confidence interval; Log-rank test; Colorectal cancer; Cancer","score_opus":0.16787399247325435,"score_gpt":0.5265000442890272,"score_spread":0.35862605181577284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386878679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7620333,0.01501044,0.00001481587,0.18458685,0.00013569262,0.002343218,0.00017576263,0.00014279886,0.035557114],"genre_scores_gemma":[0.98426867,0.010013291,0.00015696108,0.00013842538,0.000014952709,0.0013795113,0.00006381054,0.00002280453,0.0039415844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798703,0.00075881695,0.00029541756,0.00016890149,0.0004356806,0.00035417557],"domain_scores_gemma":[0.9956376,0.0019072847,0.000054042957,0.001808569,0.0004860675,0.00010646109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020770764,0.00008082148,0.0001623554,0.00037256652,0.0004892959,0.0000344162,0.00058018346,0.000054801025,0.00007967016],"category_scores_gemma":[0.0010884114,0.00005770027,0.000060171515,0.0027382623,0.0005807463,0.0000641475,0.00036467257,0.00037447302,0.00009417798],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026457684,0.0049044862,0.035535958,0.00050398515,0.002862396,0.0004951062,0.03894216,0.00010532828,0.25498655,0.053122047,0.2814494,0.3006349],"study_design_scores_gemma":[0.0058486313,0.00057004846,0.3942665,0.0008757737,0.00010835936,0.000030893014,0.0061543467,0.0026486507,0.0014890995,0.0028135679,0.5849967,0.00019744357],"about_ca_topic_score_codex":0.0026752558,"about_ca_topic_score_gemma":0.0013016325,"teacher_disagreement_score":0.35873052,"about_ca_system_score_codex":0.00041727335,"about_ca_system_score_gemma":0.0015117823,"threshold_uncertainty_score":0.40442044},"labels":[],"label_agreement":null},{"id":"W4387865430","doi":"10.1158/2767-9764.crc-23-0289","title":"Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Chromosomal and Genetic Variations","field":"Agricultural and Biological Sciences","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; Yale University; University of British Columbia; Roswell Park Cancer Institute","keywords":"Antigen; Carcinogenesis; Cancer; Immune system; Autoantibody; Antibody; Immunology; Biology; Retrotransposon; Clinical significance; Pancreatic cancer; Cancer research; Immunoassay; Medicine; Pathology; Genetics; Gene; Genome","score_opus":0.23013557270925114,"score_gpt":0.43451549802623435,"score_spread":0.2043799253169832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387865430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857834,0.002977334,6.8452584e-7,0.008865784,0.000045366578,0.0002513123,0.00019184563,0.000048976493,0.0018353241],"genre_scores_gemma":[0.9741607,0.024994828,0.000092733215,0.00003864646,0.000082024606,0.0002263196,0.00009754441,0.0000016057708,0.00030564837],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99867845,0.0002281924,0.00027189267,0.00019749241,0.0002919612,0.0003320387],"domain_scores_gemma":[0.99847513,0.00077445,0.00006697481,0.0003154308,0.00031233605,0.00005567122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006087856,0.000073393225,0.00014366621,0.00006592834,0.0005022947,0.000028169516,0.0007942736,0.00005377342,0.00015077196],"category_scores_gemma":[0.00026771106,0.000038058854,0.000051732524,0.002023801,0.00025743875,0.00007185322,0.0004421206,0.00028487702,0.000026087318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000058463443,0.00012215934,0.17191954,0.000028595672,0.000022172202,0.000001944186,0.0012842729,0.0010764131,0.7622256,0.002021767,0.0005663035,0.060725372],"study_design_scores_gemma":[0.0001562569,0.000044994456,0.9636426,0.00030655798,0.0000048004417,2.5137655e-7,0.0012323954,0.0036679353,0.0037258898,0.0025692685,0.024487937,0.00016114261],"about_ca_topic_score_codex":0.0035858308,"about_ca_topic_score_gemma":0.040727362,"teacher_disagreement_score":0.791723,"about_ca_system_score_codex":0.000073012015,"about_ca_system_score_gemma":0.000071397415,"threshold_uncertainty_score":0.97677684},"labels":[],"label_agreement":null},{"id":"W4389085040","doi":"10.1158/2767-9764.crc-23-0223","title":"Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a <i>BRCA1</i> or <i>BRCA2</i> Mutation","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Physical Activity and Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Amgen (Canada); Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Institute of Genetics; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Peter Gilgan Foundation; Women's College Hospital; Cleveland Clinic","keywords":"Medicine; Ovarian cancer; Metabolic equivalent; Confidence interval; Young adult; Internal medicine; Physical activity; Cancer; Case-control study; Logistic regression; Oncology; Population; Demography; Physiology; Physical therapy; Environmental health","score_opus":0.1168879454881964,"score_gpt":0.43710140319247803,"score_spread":0.32021345770428167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389085040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678905,0.00020362217,0.000013728096,0.011842911,0.000010969863,0.0007166815,0.000038481576,0.0001074365,0.0002770976],"genre_scores_gemma":[0.99385345,0.004110724,0.000084380474,0.00006410652,0.0001146419,0.0013511446,0.0000051595384,0.00002846418,0.00038792394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982594,0.00028077725,0.000112353795,0.00034760215,0.0004539946,0.0005458301],"domain_scores_gemma":[0.9980578,0.000434013,0.00006134604,0.00080237124,0.00024414234,0.0004003472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041860118,0.00013321695,0.00031190214,0.00016200848,0.0008227118,0.000071172304,0.00024350279,0.000058728147,0.000012215257],"category_scores_gemma":[0.0001230154,0.00010422734,0.000019759018,0.0011531054,0.00083483785,0.000371318,0.00041447053,0.00097598514,0.000007576435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012610874,0.00661127,0.34615764,0.0059888596,0.0009066768,0.00019281285,0.122245245,0.00007604775,0.22043052,0.003250165,0.0012696061,0.2802603],"study_design_scores_gemma":[0.0017907943,0.0005178016,0.9905913,0.00070277485,0.000029333249,0.000010772376,0.0010300726,0.0016139703,0.0027865642,0.00032241343,0.00044742192,0.00015676666],"about_ca_topic_score_codex":0.002881563,"about_ca_topic_score_gemma":0.0017319274,"teacher_disagreement_score":0.6444337,"about_ca_system_score_codex":0.00035408683,"about_ca_system_score_gemma":0.00055746373,"threshold_uncertainty_score":0.6327717},"labels":[],"label_agreement":null},{"id":"W4389180294","doi":"10.1158/2767-9764.crc-23-0306","title":"<i>FBXW7</i> -loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; York University; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Government of Canada","keywords":"Mitotic catastrophe; DNA damage; Biology; CHEK1; Mitosis; DNA repair; Cell biology; Cell cycle; G2-M DNA damage checkpoint; DNA replication; Mutant; Synthetic lethality; Mutation; Cell cycle checkpoint; Cancer research; Cell; Gene; Genetics; DNA","score_opus":0.09873208563061066,"score_gpt":0.4102092194617746,"score_spread":0.31147713383116393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389180294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98895425,0.00067433243,0.00032532463,0.00802564,0.00012895602,0.0005593918,0.00025020292,0.000051094892,0.0010308382],"genre_scores_gemma":[0.98959196,0.0060458123,0.0012332783,0.00055342494,0.00020614962,0.00041537936,0.00077633944,0.000038471488,0.0011391753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842703,0.00032298133,0.00019963403,0.00033186894,0.00025059472,0.00046785868],"domain_scores_gemma":[0.9975202,0.00007542575,0.000037364538,0.0018361759,0.00039688472,0.00013395623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000458449,0.00012311674,0.00012139553,0.00011497271,0.00048520722,0.000059574915,0.0006852694,0.00012092715,0.000016853357],"category_scores_gemma":[0.00011609252,0.00013146817,0.00006885355,0.00076431216,0.00020683737,0.0000092529135,0.0011924795,0.00033915366,0.00030563617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021216034,0.000042487725,0.00008526553,0.000016831344,0.000028982768,0.0000034377679,0.0002738374,0.000111032845,0.93984306,0.00023893935,0.05841689,0.0009180453],"study_design_scores_gemma":[0.00034272112,0.00014536781,0.00041525238,0.00007095749,0.000012675977,0.0000064496135,0.0005493987,0.00012606454,0.75848866,0.0002091535,0.23941496,0.0002183165],"about_ca_topic_score_codex":0.0006256766,"about_ca_topic_score_gemma":0.0014525465,"teacher_disagreement_score":0.18135436,"about_ca_system_score_codex":0.00008820796,"about_ca_system_score_gemma":0.0002636761,"threshold_uncertainty_score":0.53611165},"labels":[],"label_agreement":null},{"id":"W4389180400","doi":"10.1158/2767-9764.crc-23-0234","title":"SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in Neuroblastoma","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Scheme for Promotion of Academic and Research Collaboration; Canadian Institutes of Health Research; Hospital for Sick Children; Government of Canada; Novartis","keywords":"Crizotinib; Neuroblastoma; ALK inhibitor; Cancer research; Anaplastic lymphoma kinase; Ceritinib; In vivo; Biology; Cell culture; Medicine; Lung cancer; Internal medicine; Genetics","score_opus":0.0929202335907669,"score_gpt":0.4231044218699909,"score_spread":0.330184188279224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389180400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892445,0.0014346782,8.6965696e-7,0.0060490803,0.000008006009,0.00083745434,0.000049019818,0.000064161,0.0023121973],"genre_scores_gemma":[0.99145645,0.0071245413,0.00018684486,0.00003800289,0.000018887971,0.00041380746,0.000051493684,0.000029828696,0.00068016327],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979433,0.00042317397,0.00025745388,0.00028108113,0.000675342,0.00041963972],"domain_scores_gemma":[0.99716383,0.0011173052,0.000054681936,0.0011219237,0.0003212936,0.00022096992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054786244,0.000119030825,0.00024277616,0.0007881468,0.00022159015,0.000029404313,0.00024885347,0.000047197656,0.000023805564],"category_scores_gemma":[0.0005547734,0.00010036799,0.000032194355,0.0022113493,0.0008375767,0.00015303487,0.0004698299,0.0005382766,0.000021205526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016427353,0.009411609,0.38552648,0.003282799,0.00085368444,0.001818597,0.0046646395,0.00015844227,0.46553677,0.012412808,0.043656435,0.056250405],"study_design_scores_gemma":[0.007872833,0.0013462167,0.9524467,0.0028161446,0.000037280173,0.000033614888,0.00058044045,0.0002592133,0.024498124,0.00064765,0.009255632,0.00020615733],"about_ca_topic_score_codex":0.0010085455,"about_ca_topic_score_gemma":0.004312618,"teacher_disagreement_score":0.5669202,"about_ca_system_score_codex":0.00016625886,"about_ca_system_score_gemma":0.00041321208,"threshold_uncertainty_score":0.4092888},"labels":[],"label_agreement":null},{"id":"W4389436951","doi":"10.1158/2767-9764.crc-23-0361","title":"A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial","year":2023,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Sanofi; Merck KGaA; Les Laboratories Pierre Fabre; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company; Chugai Pharmaceutical; Servier; Göteborgs Universitet; G1 Therapeutics; Amgen","keywords":"Medicine; Oxaliplatin; Bevacizumab; Clinical endpoint; Fluorouracil; Internal medicine; Colorectal cancer; Randomized controlled trial; Adverse effect; Phases of clinical research; Bolus (digestion); Gastroenterology; Oncology; Surgery; Cancer; Clinical trial; Chemotherapy","score_opus":0.3327243693725975,"score_gpt":0.5179726216997274,"score_spread":0.18524825232712988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389436951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774584,0.007872668,0.00000929841,0.0033660494,0.00007713041,0.01059392,0.00033113177,0.000026273534,0.00026509791],"genre_scores_gemma":[0.9477274,0.02539431,0.000099061865,0.000004156172,0.00005655436,0.02631289,0.000065889544,0.000021382004,0.00031839593],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99797124,0.00046401907,0.00050249405,0.00025437205,0.00049486326,0.00031303675],"domain_scores_gemma":[0.9940667,0.0041859676,0.00019705604,0.00081721955,0.0006346125,0.00009842944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095006835,0.00017983906,0.00091274973,0.00018916483,0.0005972858,0.000018590325,0.00025768418,0.000026520287,0.000033938875],"category_scores_gemma":[0.00033320818,0.00010191142,0.0001410533,0.0007253156,0.00075143797,0.00004443525,0.00019527406,0.00014425714,6.7900277e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.947957,0.0036982317,0.00034056223,0.00011324437,0.004220005,0.0000055787314,0.015176965,0.000085281456,0.00008791101,0.00047429715,0.00019192086,0.027649015],"study_design_scores_gemma":[0.9580878,0.024942333,0.00051273446,0.0001230633,0.0015832685,0.0000017824274,0.010070052,0.0016893917,0.0006152832,0.00012093957,0.0021510911,0.00010225812],"about_ca_topic_score_codex":0.00948758,"about_ca_topic_score_gemma":0.024298655,"teacher_disagreement_score":0.029731069,"about_ca_system_score_codex":0.00047972458,"about_ca_system_score_gemma":0.0005560485,"threshold_uncertainty_score":0.99710834},"labels":[],"label_agreement":null},{"id":"W4391644521","doi":"10.1158/2767-9764.crc-23-0409","title":"Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital; Sinai Health System; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Genentech; National Institutes of Health; Bayer HealthCare; Flatiron Health; Seagen; Gilead Sciences; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; American Society of Clinical Oncology; GlaxoSmithKline; Amgen; Pfizer","keywords":"Medicine; Colorectal cancer; Cancer; Oncology; Internal medicine","score_opus":0.07539687396634995,"score_gpt":0.43334037967332933,"score_spread":0.3579435057069794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391644521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97657734,0.008497981,0.000009289867,0.009658702,0.00011777306,0.0008101274,0.004200053,0.000030119976,0.00009863927],"genre_scores_gemma":[0.98452187,0.013729608,0.00027580844,0.00017435974,0.00012341447,0.0003744751,0.00062883797,0.00002296968,0.00014864671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984303,0.00037917012,0.0003346925,0.00025012193,0.0003843663,0.00022135934],"domain_scores_gemma":[0.99766916,0.00088643143,0.00009174739,0.000600555,0.000640804,0.00011131888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004281017,0.00012441614,0.00029667004,0.00006862063,0.0003620465,0.00008334089,0.0003900921,0.00006326089,0.00016636279],"category_scores_gemma":[0.00012428073,0.00007510032,0.00005921078,0.0005217446,0.0014326139,0.00012449209,0.0002904335,0.00052381225,0.0000064401693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006297584,0.00030971158,0.95282483,0.000098609045,0.0009231449,0.0000071817863,0.0017739319,8.1985013e-7,0.029409062,0.000964808,0.00096447434,0.0120936455],"study_design_scores_gemma":[0.00064456934,0.00021383604,0.97036755,0.0002452903,0.00018763242,0.0000012500494,0.0006205901,0.00017162193,0.001593711,0.000021462825,0.025844032,0.000088428234],"about_ca_topic_score_codex":0.0021531757,"about_ca_topic_score_gemma":0.0009772923,"teacher_disagreement_score":0.02781535,"about_ca_system_score_codex":0.00012832397,"about_ca_system_score_gemma":0.0008695146,"threshold_uncertainty_score":0.5278526},"labels":[],"label_agreement":null},{"id":"W4391884468","doi":"10.1158/2767-9764.crc-23-0571","title":"Cancer-associated Fibroblast–specific Expression of the Matricellular Protein CCN1 Coordinates Neovascularization and Stroma Deposition in Melanoma Metastasis","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Connective Tissue Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Alberta; University of Saskatchewan; Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Arthritis Society","keywords":"Matricellular protein; Stroma; Metastasis; Neovascularization; Cancer; Cancer research; Melanoma; Pathology; Cancer-Associated Fibroblasts; Biology; Extracellular matrix; Immunohistochemistry; Medicine; Cell biology; Angiogenesis; Genetics","score_opus":0.05572409140274851,"score_gpt":0.37153160226177345,"score_spread":0.3158075108590249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391884468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539372,0.042882122,0.00029530644,0.0017123809,0.00002422552,0.00088114146,0.00012262967,0.000012788202,0.00013221915],"genre_scores_gemma":[0.9946931,0.0039786184,0.00019960066,0.0000035127664,0.000026045662,0.0007364217,0.00009717469,0.000025143278,0.00024040861],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978562,0.0009897497,0.00021905676,0.0003041247,0.00036636327,0.00026448487],"domain_scores_gemma":[0.9985028,0.00013608097,0.000050600633,0.0009061175,0.00034787893,0.000056543082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007828355,0.000104739665,0.00012915801,0.00020457804,0.0002589522,0.0000827672,0.00066218316,0.000105662315,0.000041997282],"category_scores_gemma":[0.00024094964,0.00008757298,0.00006470845,0.00097592315,0.00032682955,0.00001926649,0.0008383881,0.00039760442,0.0000018601843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000326912,0.000065042164,0.0034904578,0.00009441075,0.000056683497,0.0000010418861,0.00016207145,0.0000326172,0.9909204,0.0004954494,0.00026006202,0.00438907],"study_design_scores_gemma":[0.00035081606,0.00011075155,0.014954112,0.0007037186,0.000013259353,0.000001678442,0.00018620216,0.0008396696,0.9778322,0.00031110292,0.004578828,0.000117659016],"about_ca_topic_score_codex":0.0012900094,"about_ca_topic_score_gemma":0.0014519824,"teacher_disagreement_score":0.040755887,"about_ca_system_score_codex":0.00019130595,"about_ca_system_score_gemma":0.00025952802,"threshold_uncertainty_score":0.35711226},"labels":[],"label_agreement":null},{"id":"W4391884527","doi":"10.1158/2767-9764.crc-22-0516","title":"CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Chugai Pharmaceutical; Stand Up To Cancer; Genentech; Ipsen; Servier; Eisai; Incyte; Astex Pharmaceuticals; Novocure; Sanofi; Exelixis; BioClinica; Regeneron Pharmaceuticals; National Institutes of Health; Helsinn; Gilead Sciences; Celgene; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Sorafenib; Hepatocellular carcinoma; Medicine; Hepatitis C virus; Internal medicine; Hepatitis C; Titer; Gastroenterology; Hepacivirus; Discontinuation; Immunology; Oncology; Virus","score_opus":0.07582060412169538,"score_gpt":0.4308331225200983,"score_spread":0.3550125183984029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391884527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925487,0.0027484486,0.000039279996,0.00080652116,0.000017692872,0.00182904,0.000117640266,0.00005103133,0.0018416613],"genre_scores_gemma":[0.9892971,0.009074286,0.0004939745,0.000020609692,0.00002184309,0.00073647837,0.00010578222,0.000066272194,0.00018367087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727094,0.00044033703,0.0003287237,0.00042720712,0.0009957869,0.0005370281],"domain_scores_gemma":[0.99700165,0.00030484574,0.000056494417,0.0015110912,0.00085535645,0.0002705848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006662207,0.00020737958,0.0003961673,0.0006565191,0.00020045399,0.000067255445,0.00032716928,0.000098074204,0.00010536946],"category_scores_gemma":[0.00019122541,0.00015109366,0.0000584767,0.0017243272,0.0007900429,0.00027037616,0.00021784172,0.0012382336,0.000019753417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009045774,0.00032396414,0.9784538,0.00026776807,0.00012153309,0.000015760328,0.00048762545,0.000057251928,0.00084734464,0.0002656307,0.00015038202,0.018104333],"study_design_scores_gemma":[0.0024819064,0.0030558088,0.9840279,0.001904308,0.000028454606,0.0000031546742,0.000025521509,0.0057431883,0.0009664074,0.00005039583,0.0015492003,0.00016372267],"about_ca_topic_score_codex":0.026961071,"about_ca_topic_score_gemma":0.0092379255,"teacher_disagreement_score":0.017940613,"about_ca_system_score_codex":0.001176175,"about_ca_system_score_gemma":0.0012818704,"threshold_uncertainty_score":0.9795185},"labels":[],"label_agreement":null},{"id":"W4392298413","doi":"10.1158/2767-9764.crc-23-0269","title":"Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Terry Fox Research Institute; Princess Margaret Cancer Foundation","keywords":"Photodynamic therapy; Basal cell; Oral cavity; Medicine; Cancer research; Oncology; Pathology; Chemistry; Dentistry","score_opus":0.21334741227809056,"score_gpt":0.5269626874590205,"score_spread":0.31361527518092996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392298413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516553,0.022140518,0.00012402688,0.019310191,0.00007269681,0.002753321,0.00014053672,0.00018523801,0.0036181319],"genre_scores_gemma":[0.9848496,0.0079898415,0.0016068211,0.00048718927,0.000045959667,0.0032692372,0.000053434836,0.000082112245,0.0016158327],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99462426,0.0019775738,0.00058870786,0.0007034703,0.0010313014,0.0010747025],"domain_scores_gemma":[0.9928609,0.0034774912,0.000037663856,0.002464901,0.0005952043,0.00056384096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004795856,0.00025923862,0.00053638325,0.0008048906,0.00037410116,0.00013138303,0.0013384147,0.00016075543,0.00025283793],"category_scores_gemma":[0.0007166604,0.00022500199,0.00015911856,0.0027395752,0.00057270256,0.00023529714,0.0010275982,0.0021176287,0.00023428146],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028451162,0.0021371187,0.0023933642,0.0003789989,0.00025093736,0.00024147659,0.011779261,0.0010819767,0.9163063,0.0015821148,0.003762613,0.057240702],"study_design_scores_gemma":[0.011655756,0.0046846755,0.039568312,0.0011525445,0.00012240224,0.00008376019,0.003060879,0.7401699,0.10408151,0.015793547,0.07828727,0.0013394791],"about_ca_topic_score_codex":0.014259132,"about_ca_topic_score_gemma":0.005848662,"teacher_disagreement_score":0.8122248,"about_ca_system_score_codex":0.0013619453,"about_ca_system_score_gemma":0.0019637146,"threshold_uncertainty_score":0.992305},"labels":[],"label_agreement":null},{"id":"W4392298469","doi":"10.1158/2767-9764.crc-23-0376","title":"Dabrafenib Alters MDSC Differentiation and Function by Activation of GCN2","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; Canadian Institutes of Health Research; Canada First Research Excellence Fund; Terry Fox Research Institute","keywords":"Dabrafenib; Function (biology); Immunologic function; Chemistry; Cell biology; Neuroscience; Medicine; Cancer research; Biology; Immunology; Immune system; Melanoma","score_opus":0.07591477353296165,"score_gpt":0.3923209270614251,"score_spread":0.3164061535284634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392298469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6025845,0.35780624,0.006871856,0.017567348,0.0021107101,0.0016021308,0.0003589875,0.00032788224,0.01077038],"genre_scores_gemma":[0.9871658,0.009349955,0.000051544484,0.000034313067,0.000019458646,0.0002726313,0.00035404754,0.000019252668,0.0027329773],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987925,0.00046006244,0.00022372665,0.00021233187,0.00008552519,0.00022582432],"domain_scores_gemma":[0.9983017,0.0006033032,0.000051234176,0.0008107745,0.0002157254,0.000017266231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005467233,0.000088444416,0.00012491069,0.00022539777,0.00033512877,0.00004139416,0.00042834555,0.00012749607,0.00048386145],"category_scores_gemma":[0.00008582669,0.00008475534,0.00003639056,0.00041033883,0.00064094586,0.00021516392,0.00031144277,0.00061143714,0.00006244924],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000608836,0.000065762506,0.00036438147,0.00009407057,0.00016493634,4.777966e-8,0.00069977285,0.0000040107548,0.89215,0.0053327205,0.057458766,0.043604683],"study_design_scores_gemma":[0.0006408517,0.00013877136,0.0044228826,0.00037665144,0.000056411776,0.0000025998474,0.0005192162,0.0003366549,0.41574472,0.0019750998,0.57561505,0.00017110117],"about_ca_topic_score_codex":0.0006095931,"about_ca_topic_score_gemma":0.00007206843,"teacher_disagreement_score":0.5181563,"about_ca_system_score_codex":0.00018956006,"about_ca_system_score_gemma":0.00015586038,"threshold_uncertainty_score":0.52979434},"labels":[],"label_agreement":null},{"id":"W4393026261","doi":"10.1158/2767-9764.crc-23-0384","title":"Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; McGill University","keywords":"Mimotope; Immunogenicity; Epitope; Biology; Virology; Antigen; Immunology","score_opus":0.09703523020333038,"score_gpt":0.4529567443100348,"score_spread":0.3559215141067044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393026261","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13384949,0.83014685,0.0037448253,0.02837523,0.0009922171,0.0019379513,0.00046714218,0.00010951709,0.0003767591],"genre_scores_gemma":[0.8680147,0.12008733,0.000038951566,0.000046427227,0.00004007151,0.0024229966,0.00006632441,0.000024905426,0.0092583075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984068,0.00053469074,0.00042074663,0.0002222237,0.000079161466,0.0003363242],"domain_scores_gemma":[0.9953585,0.0024210578,0.000085655985,0.0015951248,0.0005272632,0.000012381041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001607096,0.000112963055,0.00018733925,0.00021885459,0.00082726043,0.000059466747,0.0015049619,0.00010429557,0.00066597294],"category_scores_gemma":[0.00025438736,0.00008074608,0.00012405566,0.00056490867,0.0005641875,0.00013782867,0.00027331253,0.00048507183,0.000080552556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026898098,0.000076172095,0.00005470206,0.00007703485,0.0004466668,7.320182e-8,0.0012337489,0.000015123141,0.9158226,0.003748145,0.009723959,0.06853278],"study_design_scores_gemma":[0.0003483619,0.000057181205,0.0023545243,0.00015616982,0.000030304443,0.000001528372,0.0003732924,0.0001414454,0.53863215,0.0003115721,0.45752004,0.00007340356],"about_ca_topic_score_codex":0.0012752158,"about_ca_topic_score_gemma":0.00045353084,"teacher_disagreement_score":0.7341652,"about_ca_system_score_codex":0.000106576,"about_ca_system_score_gemma":0.00040722746,"threshold_uncertainty_score":0.7291936},"labels":[],"label_agreement":null},{"id":"W4394567449","doi":"10.1158/2767-9764.crc-23-0519","title":"<i>Actívatexto:</i> Feasibility and Acceptability of a Mobile Intervention That Promotes Smoking Cessation and Physical Activity among Latinos","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority","funders":"Genentech; National Institute of Environmental Health Sciences; American Association for Cancer Research","keywords":"Smoking cessation; Medicine; Abstinence; Nicotine replacement therapy; Physical activity; Intervention (counseling); Physical therapy; Psychiatry","score_opus":0.2299298449951721,"score_gpt":0.5019009863141938,"score_spread":0.27197114131902167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394567449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965478,0.001472939,0.00006752204,0.0005247227,0.000032148844,0.0008764807,0.000036591955,0.00005711703,0.0003846766],"genre_scores_gemma":[0.99855345,0.0008100692,0.000048125,0.0000029241546,0.000027318798,0.00047557126,0.000032433043,0.000013253865,0.000036878173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866694,0.00038078547,0.0001535117,0.00027166842,0.00037528388,0.000151789],"domain_scores_gemma":[0.9983843,0.00045894965,0.000057167334,0.0007697317,0.00025165503,0.000078226636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013205957,0.00008575641,0.00018255626,0.00013702616,0.00020880158,0.00008610264,0.00015311624,0.00007143501,0.000091023285],"category_scores_gemma":[0.0001811813,0.000076559154,0.000060142043,0.00039449323,0.0007228334,0.00037514098,0.00029794074,0.0005706328,3.4566358e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035778197,0.00038166434,0.8151561,0.00049925275,0.000031712112,3.6114176e-7,0.0024485716,6.7223044e-7,0.0048405854,0.00018244689,0.00001938282,0.17640345],"study_design_scores_gemma":[0.00034612257,0.00013067316,0.9811175,0.0003285767,0.00007370593,0.000002122544,0.0007332737,0.0021788857,0.01423921,0.00064287626,0.00014605468,0.000060984963],"about_ca_topic_score_codex":0.0016816395,"about_ca_topic_score_gemma":0.0002503676,"teacher_disagreement_score":0.17634246,"about_ca_system_score_codex":0.00024170401,"about_ca_system_score_gemma":0.00011140548,"threshold_uncertainty_score":0.31219918},"labels":[],"label_agreement":null},{"id":"W4395663602","doi":"10.1158/2767-9764.crc-23-0459","title":"First-line Avelumab plus Chemotherapy in Patients with Advanced Solid Tumors: Results from the Phase Ib/II JAVELIN Chemotherapy Medley Study","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"Merck KGaA; Pfizer","keywords":"Javelin; Avelumab; Chemotherapy; Medicine; Solid tumor; Oncology; Internal medicine; Cancer; Immunotherapy; Pembrolizumab; Physics","score_opus":0.08169363019912536,"score_gpt":0.4397402393431038,"score_spread":0.35804660914397846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395663602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9297812,0.01527088,0.00003737511,0.049615566,0.000119622,0.003994785,0.00055611134,0.0001316342,0.0004928254],"genre_scores_gemma":[0.9784301,0.017783662,0.0003741957,0.00087801286,0.00017256623,0.0012683991,0.0004155276,0.00009250629,0.0005850301],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99667263,0.0004035322,0.0007186824,0.0006221544,0.0010083171,0.0005746647],"domain_scores_gemma":[0.99498785,0.0010482804,0.000114469396,0.0031695412,0.00052712834,0.0001527165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016243516,0.00029148854,0.00046301653,0.00023808949,0.00074866816,0.00013520767,0.0013500277,0.00009770129,0.000345199],"category_scores_gemma":[0.00020290457,0.00019363366,0.00011170305,0.0017924776,0.0006526016,0.00020541062,0.00030414294,0.0012644636,0.000021596512],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1309828,0.018571971,0.01845906,0.00022201169,0.0033255809,0.0000700007,0.10358294,0.00033991312,0.0038865244,0.00014738922,0.03378359,0.6866282],"study_design_scores_gemma":[0.21380337,0.013015369,0.2690086,0.0076063676,0.00020280259,0.000007434064,0.0100956205,0.0125165535,0.0029255045,0.0005391414,0.46903348,0.0012457626],"about_ca_topic_score_codex":0.005475398,"about_ca_topic_score_gemma":0.008188788,"teacher_disagreement_score":0.6853825,"about_ca_system_score_codex":0.0012042049,"about_ca_system_score_gemma":0.0011864817,"threshold_uncertainty_score":0.8277201},"labels":[],"label_agreement":null},{"id":"W4396676987","doi":"10.1158/2767-9764.crc-24-0031","title":"Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon Cancer Recurrence","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"AI in cancer detection","field":"Computer Science","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Institutes of Health; National Cancer Institute; Sanofi; Mayo Clinic; Center for Cancer Research","keywords":"Colorectal cancer; Deep learning; Artificial intelligence; Medicine; Internal medicine; Oncology; Cancer; Computer science","score_opus":0.18696357518641435,"score_gpt":0.44859527983426,"score_spread":0.2616317046478457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396676987","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39476854,0.11006196,0.44959816,0.028898226,0.00340997,0.009119274,0.0024884187,0.00070152676,0.000953923],"genre_scores_gemma":[0.96617156,0.005769936,0.02505781,0.000040496056,0.000066402456,0.0024894902,0.000020243282,0.000023243772,0.00036081517],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981142,0.00040849927,0.00029765264,0.00035992754,0.00052909454,0.0002906193],"domain_scores_gemma":[0.9972798,0.00087108935,0.000090885755,0.0012328777,0.00043546784,0.00008987769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010988935,0.00009970925,0.00015385546,0.00032569212,0.00033123608,0.00011347617,0.0014893487,0.00004700631,0.000028452254],"category_scores_gemma":[0.0002512314,0.00010284494,0.00007158694,0.0010814626,0.00030893722,0.00048175314,0.00085591763,0.0005022267,0.0000061037267],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016083311,0.0001657134,0.0021201787,0.0005063942,0.00018133072,9.449105e-7,0.0070989747,0.016214356,0.30580932,0.005560864,0.014353371,0.6478277],"study_design_scores_gemma":[0.0005500477,0.001203321,0.019547,0.0017129107,0.00007325638,0.000013238467,0.0005031415,0.57750666,0.18125026,0.0018575203,0.21543182,0.0003508358],"about_ca_topic_score_codex":0.0012370595,"about_ca_topic_score_gemma":0.0008987378,"teacher_disagreement_score":0.64747685,"about_ca_system_score_codex":0.0007760105,"about_ca_system_score_gemma":0.0003364941,"threshold_uncertainty_score":0.4193895},"labels":[],"label_agreement":null},{"id":"W4399365549","doi":"10.1158/2767-9764.crc-24-0048","title":"Cancer-Related Fatigue and the Additive Effect of Treatment in the Context of Lymphoma: An Analysis of the Lymphoma Coalition’s 2022 Global Patient Survey","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Pharmacyclics; Gilead Sciences; Kite Pharma; Incyte; AbbVie; Roche; Novartis; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Allergan; AstraZeneca United States","keywords":"Chronic lymphocytic leukemia; Medicine; Lymphoma; Context (archaeology); Incidence (geometry); Etiology; Survivorship curve; Cancer; Internal medicine; Population; Disease; Oncology; Leukemia; Malignant lymphoma; Environmental health","score_opus":0.0766901425229995,"score_gpt":0.43041275368428644,"score_spread":0.35372261116128695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399365549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957497,0.032339327,0.0000022245345,0.0037258586,0.0000776299,0.0013080393,0.0042489674,0.0000091858,0.0007917679],"genre_scores_gemma":[0.9888671,0.009507428,0.0000018048481,0.000057684472,0.0000089239165,0.0012561552,0.00025435252,0.000008525713,0.000038038674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940622,0.0046473034,0.00039338286,0.00019180542,0.00052835967,0.00017694519],"domain_scores_gemma":[0.9941708,0.0035498282,0.00012059353,0.0016065346,0.00050052063,0.000051717194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022472956,0.0001162625,0.00043699337,0.00016986606,0.00018206696,0.000021581154,0.0006282907,0.00005921444,0.00007201403],"category_scores_gemma":[0.0002573461,0.000056239838,0.00020017009,0.002985249,0.0012437003,0.00004975711,0.00020834724,0.00015275241,3.265891e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031160044,0.0015015963,0.43135205,0.0004893775,0.008629171,0.000005638373,0.12578197,0.00022151413,0.00026626635,0.02125792,0.0022725577,0.40510595],"study_design_scores_gemma":[0.005133965,0.0012327657,0.95372415,0.0007665209,0.0022123395,0.000003881473,0.020842852,0.009685773,0.0017417104,0.00024261816,0.00427911,0.00013432199],"about_ca_topic_score_codex":0.33408013,"about_ca_topic_score_gemma":0.421739,"teacher_disagreement_score":0.5223721,"about_ca_system_score_codex":0.0012030617,"about_ca_system_score_gemma":0.0010468458,"threshold_uncertainty_score":0.6703543},"labels":[],"label_agreement":null},{"id":"W4399806161","doi":"10.1158/2767-9764.crc-23-0464","title":"KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"KRAS; GLI2; Cancer research; Transcription (linguistics); Carcinogenesis; Transcription factor; Pancreatic cancer; Chemistry; Biology; Internal medicine; Medicine; Genetics; Mutation; Gene; Cancer","score_opus":0.19194497592065668,"score_gpt":0.4782653957776401,"score_spread":0.2863204198569834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399806161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9007891,0.059085246,0.00014868428,0.02226568,0.00009267779,0.0014150095,0.0000558231,0.00022515339,0.015922643],"genre_scores_gemma":[0.9573128,0.030112933,0.0007328811,0.000041444226,0.00018085272,0.0017925573,0.00005211821,0.00004669673,0.009727675],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971968,0.000610869,0.0003423783,0.00038577622,0.0008431091,0.00062109914],"domain_scores_gemma":[0.9967873,0.0006504408,0.000022763552,0.0017215777,0.00051304785,0.00030485317],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015281221,0.00014973346,0.00036067195,0.0005157629,0.0006845131,0.00011328768,0.000645177,0.00013604846,0.0010428964],"category_scores_gemma":[0.00025443497,0.0001288946,0.00012209555,0.0009794886,0.0006603353,0.00015878142,0.00021053065,0.0010658504,0.00039317633],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064358907,0.0011729121,0.1260236,0.004088077,0.0016579332,0.00032360607,0.009434895,0.000008323581,0.79616565,0.022358727,0.005424645,0.03269801],"study_design_scores_gemma":[0.0073622772,0.002183552,0.7024101,0.009270941,0.0026946007,0.00095418736,0.006274263,0.026401086,0.09554953,0.014583241,0.13086496,0.0014512766],"about_ca_topic_score_codex":0.0013560166,"about_ca_topic_score_gemma":0.00065106933,"teacher_disagreement_score":0.7006161,"about_ca_system_score_codex":0.0008167171,"about_ca_system_score_gemma":0.0015720273,"threshold_uncertainty_score":0.9998703},"labels":[],"label_agreement":null},{"id":"W4399891500","doi":"10.1158/2767-9764.crc-23-0334","title":"PTP4A2 Promotes Glioblastoma Progression and Macrophage Polarization under Microenvironmental Pressure","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cancer research; Tumor microenvironment; Glioblastoma; Cell growth; Tumor progression; Apoptosis; In vitro; Glioma; Spheroid; Biology; Cancer; Chemistry; Medicine; Tumor cells; Internal medicine","score_opus":0.03352337779728468,"score_gpt":0.3976017331967693,"score_spread":0.3640783553994846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399891500","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22220375,0.7670612,0.00090761733,0.007375817,0.000085203676,0.0013696355,0.00055041874,0.000076081975,0.00037032508],"genre_scores_gemma":[0.98955584,0.0073919506,0.0012697029,0.000048150676,0.000071428854,0.00042720663,0.00028431858,0.000030550073,0.0009208722],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893594,0.00021915293,0.00011723663,0.0002967156,0.00019925024,0.00023168717],"domain_scores_gemma":[0.9989228,0.000037965252,0.00002142269,0.0008649455,0.00006665332,0.00008617655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030997334,0.00009691934,0.00006438639,0.00007099642,0.0003414274,0.00013474537,0.00046654526,0.000087168846,0.000048304526],"category_scores_gemma":[0.0000678495,0.000090615795,0.000025789082,0.00019957623,0.0004983939,0.000016218253,0.0010147239,0.0002723526,0.000015073716],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044142194,0.00007404528,0.0006004379,0.00009622467,0.00006684363,0.0000018098473,0.00006993992,0.00000828448,0.9697445,0.003986966,0.003039816,0.02226699],"study_design_scores_gemma":[0.00018926738,0.00022726122,0.0021127032,0.0001763727,0.000020282932,0.0000140919665,0.000057797162,0.00061251066,0.8053248,0.0004866498,0.190642,0.00013624942],"about_ca_topic_score_codex":0.00006862561,"about_ca_topic_score_gemma":0.000081984115,"teacher_disagreement_score":0.76735204,"about_ca_system_score_codex":0.000040145984,"about_ca_system_score_gemma":0.0001246079,"threshold_uncertainty_score":0.3695205},"labels":[],"label_agreement":null},{"id":"W4400093522","doi":"10.1158/2767-9764.crc-23-0355","title":"Putrescine Supplementation Limits the Expansion of <i>pks</i> + <i>Escherichia coli</i> and Tumor Development in the Colon","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Escherichia coli; Azoxymethane; Putrescine; Biology; Metabolome; Microbiology; Bacteria; Probiotic; Bacteroidetes; Firmicutes; Gut flora; Biochemistry; Metabolite; Enzyme; Gene; 16S ribosomal RNA; Genetics; Carcinogenesis","score_opus":0.07088852213335436,"score_gpt":0.4063819860865301,"score_spread":0.3354934639531757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400093522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9570214,0.02484769,0.00017473062,0.015835475,0.000029470235,0.0007387401,0.00007115806,0.000006841679,0.0012744531],"genre_scores_gemma":[0.9890293,0.008568299,0.0005593626,0.00032351664,0.000043206815,0.0011435107,0.0001368387,0.000008756307,0.00018725013],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99905044,0.00028703676,0.00017824973,0.00014791435,0.0001842162,0.00015212546],"domain_scores_gemma":[0.9989473,0.00017074437,0.000026544485,0.00072824024,0.00010020703,0.000026918962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009634315,0.000060920665,0.00006203377,0.00005296703,0.00026698428,0.00004553833,0.000645457,0.000025601714,0.0000073115916],"category_scores_gemma":[0.000057374302,0.000039276674,0.000018018527,0.0004469705,0.00027593243,0.000006554208,0.00026028065,0.00020300134,0.000002662655],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002389805,0.000089148096,0.0005526849,0.00005063534,0.000024681007,4.0307188e-7,0.0016926181,0.000008447367,0.9616406,0.011134064,0.013186708,0.0115961],"study_design_scores_gemma":[0.00025694314,0.0000511386,0.009358385,0.00006483605,0.00001285144,0.0000023256623,0.0013392802,0.00018369265,0.21812664,0.00030620932,0.7702206,0.00007710481],"about_ca_topic_score_codex":0.00023271391,"about_ca_topic_score_gemma":0.0013495383,"teacher_disagreement_score":0.7570339,"about_ca_system_score_codex":0.000018793127,"about_ca_system_score_gemma":0.00028738525,"threshold_uncertainty_score":0.20534542},"labels":[],"label_agreement":null},{"id":"W4400228534","doi":"10.1158/2767-9764.crc-24-0113","title":"mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of <i>PIK3CA</i> -Altered Tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba; Genome British Columbia; University of Victoria; McGill University; Research Manitoba; Jewish General Hospital","funders":"","keywords":"mTORC1; PI3K/AKT/mTOR pathway; Fulvestrant; Cancer research; Medicine; Oncology; Internal medicine; Translation (biology); Breast cancer; Clinical trial; Cancer; Biology; Signal transduction; Gene; Genetics; Messenger RNA","score_opus":0.09867638834535514,"score_gpt":0.42521902088070773,"score_spread":0.3265426325353526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400228534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755035,0.019808434,0.0013722547,0.00080047577,0.000068432266,0.0013463715,0.00019869892,0.000035554276,0.0008662989],"genre_scores_gemma":[0.9925701,0.0020228429,0.0040716063,0.000017725515,0.00010585455,0.00069339207,0.00019874221,0.000051800376,0.00026794148],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99748695,0.000519258,0.0006971244,0.0004460328,0.00052774936,0.0003228915],"domain_scores_gemma":[0.99679923,0.00026966908,0.00015021976,0.0016336472,0.0010088623,0.00013839891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011348993,0.0001627837,0.00029205685,0.00013782215,0.00013194626,0.00003605477,0.0011085091,0.00019074364,0.000052651576],"category_scores_gemma":[0.00024593016,0.00014507843,0.0001147731,0.0006416399,0.0010891552,0.000013261069,0.00026010806,0.00062693265,0.0000041150843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005212837,0.00023989668,0.020954598,0.00024194989,0.00046656816,0.0000018378131,0.00036606827,0.0017521952,0.96872884,0.0014147034,0.0008154083,0.0044966387],"study_design_scores_gemma":[0.0018528319,0.0032517526,0.013437521,0.0025590921,0.00023674808,0.000016092728,0.000174803,0.022456778,0.93902427,0.0015180848,0.014827519,0.0006444944],"about_ca_topic_score_codex":0.0003778436,"about_ca_topic_score_gemma":0.0010540239,"teacher_disagreement_score":0.029704569,"about_ca_system_score_codex":0.00007016472,"about_ca_system_score_gemma":0.0013122708,"threshold_uncertainty_score":0.59161264},"labels":[],"label_agreement":null},{"id":"W4400657012","doi":"10.1158/2767-9764.crc-24-0196","title":"Estrogen Receptor Blockade Potentiates Immunotherapy for Liver Metastases by Altering the Liver Immunosuppressive Microenvironment","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Tumor microenvironment; CCL5; Immunotherapy; Cancer research; Fulvestrant; Immune system; Estrogen; Chemokine; Estrogen receptor; Immunosurveillance; Chemokine receptor; Metastasis; Medicine; Biology; T cell; Internal medicine; Immunology; Cancer; IL-2 receptor; Breast cancer","score_opus":0.06896235462557136,"score_gpt":0.37458375142484307,"score_spread":0.3056213967992717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400657012","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02211807,0.966059,0.00056579907,0.007203382,0.00074275356,0.0015753175,0.0013867479,0.000111868925,0.00023705675],"genre_scores_gemma":[0.58025175,0.3988445,0.0014215421,0.0002950839,0.0001165862,0.0064022923,0.0010842279,0.00013873143,0.01144529],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997269,0.001014789,0.00038603073,0.00044573838,0.00013633713,0.0007481213],"domain_scores_gemma":[0.9956866,0.0017924648,0.00008552478,0.0022090226,0.0001945281,0.000031876523],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011541895,0.00024889386,0.00025148992,0.0001507043,0.0015508905,0.0001884302,0.002515194,0.00016133761,0.0024283028],"category_scores_gemma":[0.00008053957,0.00019190222,0.00022511704,0.00031376956,0.0016916455,0.00019235727,0.0010204783,0.001093737,0.00064504467],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114319584,0.00012619613,0.000014397623,0.00006262178,0.0009587443,0.000001152326,0.0014122935,0.00001531631,0.8255331,0.0012425242,0.13155706,0.038962267],"study_design_scores_gemma":[0.00036848386,0.00007561488,0.000032578395,0.00014112121,0.00005681202,0.000011278083,0.000406677,0.000084930645,0.32241356,0.000101346115,0.6761577,0.00014990939],"about_ca_topic_score_codex":0.0010843419,"about_ca_topic_score_gemma":0.00004106505,"teacher_disagreement_score":0.5672145,"about_ca_system_score_codex":0.00047631428,"about_ca_system_score_gemma":0.00024995298,"threshold_uncertainty_score":0.99974895},"labels":[],"label_agreement":null},{"id":"W4401751779","doi":"10.1158/2767-9764.crc-24-0101","title":"Netrin-1 and UNC5B Cooperate with Integrins to Mediate YAP-Driven Cytostasis","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Sinai Health System; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; CancerCare Manitoba; University of Toronto","funders":"Krembil Foundation; Centre Léon Bérard; Agence Nationale de la Recherche; CancerCare Manitoba Foundation; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Cytostasis; Netrin; Integrin; Cell biology; Chemistry; Biology; Biochemistry; Receptor; Cytotoxicity","score_opus":0.10923584673785962,"score_gpt":0.440136647642519,"score_spread":0.33090080090465934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401751779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9638427,0.021336043,0.00081224734,0.009501692,0.00006830181,0.00046601356,0.00024089341,0.000056357236,0.0036757737],"genre_scores_gemma":[0.9864826,0.010140331,0.0010745613,0.00017620716,0.00010372973,0.00035030776,0.00011017859,0.000029715251,0.001532334],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886113,0.00022403845,0.00012240847,0.00030410188,0.00019886928,0.0002894293],"domain_scores_gemma":[0.9983511,0.000101102654,0.000011861924,0.0010102043,0.00032292696,0.00020277777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004955912,0.00010356791,0.00010006315,0.00014553976,0.00030205466,0.00013719128,0.0005966831,0.00007069588,0.000032709693],"category_scores_gemma":[0.00012787603,0.00008394206,0.000025305877,0.0005366319,0.00030244965,0.0000062268346,0.00055837724,0.0003867463,0.00005111255],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087233115,0.000054142794,0.00081206625,0.00005954096,0.00016132763,0.000008415005,0.0010151915,0.00025235288,0.96368814,0.0019919055,0.003857243,0.028012456],"study_design_scores_gemma":[0.00030148978,0.0005556124,0.00051418616,0.00030770613,0.000024453802,0.000013138242,0.00047008472,0.0007364052,0.110756636,0.00008622738,0.88596827,0.00026579225],"about_ca_topic_score_codex":0.0003512944,"about_ca_topic_score_gemma":0.001895596,"teacher_disagreement_score":0.882111,"about_ca_system_score_codex":0.000052588624,"about_ca_system_score_gemma":0.00052359875,"threshold_uncertainty_score":0.34230578},"labels":[],"label_agreement":null},{"id":"W4401779089","doi":"10.1158/2767-9764.crc-24-0292","title":"The Proteogenomics of Prostate Cancer Radioresistance","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"U.S. National Library of Medicine; Instituto Tecnológico de Costa Rica; National Cancer Institute; National Medical Research Council; University of Toronto; Prostate Cancer Canada; Medical Research Council; Duke-NUS Medical School; Prostate Cancer Foundation; Movember Foundation; National Institutes of Health; Cancer Research UK; Sunnybrook Foundation; U.S. Department of Defense","keywords":"Proteogenomics; Radioresistance; Prostate cancer; Prostate; Cancer; Medicine; Oncology; Cancer research; Internal medicine; Biology; Radiation therapy","score_opus":0.13958524073596099,"score_gpt":0.47609397036659623,"score_spread":0.3365087296306353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401779089","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12315367,0.7446418,0.000014816703,0.12147892,0.00023887336,0.0034225283,0.00045530984,0.00009643092,0.0064976714],"genre_scores_gemma":[0.662376,0.32786214,0.00029722817,0.00005205329,0.000066663415,0.005923037,0.00001902149,0.000026719736,0.0033771475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998621,0.00016152617,0.00026759342,0.00021559556,0.0003944822,0.00033981173],"domain_scores_gemma":[0.99713266,0.0005841942,0.000043642314,0.0015748548,0.00054655824,0.000118089214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078712514,0.000096995085,0.00016858376,0.000104637336,0.0005024594,0.00008980071,0.0005524628,0.000036903344,0.000064077496],"category_scores_gemma":[0.00009471826,0.00006290741,0.0000856146,0.0007145725,0.00085071765,0.00007217333,0.000246731,0.00047505918,0.000017814113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080809125,0.00071449124,0.037108075,0.0018923893,0.0017582924,0.000042172094,0.0060472377,0.00006989611,0.021284664,0.13428114,0.087902755,0.7080908],"study_design_scores_gemma":[0.00048246185,0.00017624613,0.007998296,0.0014554948,0.00008492658,0.000004707533,0.00029802512,0.00065608113,0.014295355,0.0019261074,0.9725252,0.00009711192],"about_ca_topic_score_codex":0.00083581853,"about_ca_topic_score_gemma":0.0009572788,"teacher_disagreement_score":0.88462245,"about_ca_system_score_codex":0.0007899232,"about_ca_system_score_gemma":0.0016191672,"threshold_uncertainty_score":0.38645625},"labels":[],"label_agreement":null},{"id":"W4402865322","doi":"10.1158/2767-9764.crc-24-0268","title":"ATF6 Promotes Colorectal Cancer Growth and Stemness by Regulating the Wnt Pathway","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Endoplasmic Reticulum Stress and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Microsemi (Canada); Discovery Centre","funders":"","keywords":"Wnt signaling pathway; ATF6; Unfolded protein response; Cell biology; Organoid; Biology; Cancer research; Cell growth; Frizzled; Endoplasmic reticulum; Signal transduction; Genetics","score_opus":0.044888252405469425,"score_gpt":0.3832452394018077,"score_spread":0.3383569869963383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402865322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8791418,0.10878377,0.000032903376,0.009008933,0.00006905526,0.00043260565,0.00026763184,0.000024640058,0.002238642],"genre_scores_gemma":[0.981369,0.016599137,0.000053594653,0.000053883112,0.00009771789,0.0010725298,0.00009547457,0.000021202059,0.00063742284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886596,0.00027791658,0.00013420114,0.000261575,0.00020567563,0.00025467842],"domain_scores_gemma":[0.9989267,0.00016778124,0.00002403589,0.00061245717,0.00016480366,0.00010424171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036607258,0.00009462925,0.00007817943,0.000033264,0.00052967784,0.00016102684,0.0005678744,0.00006159043,0.000032423508],"category_scores_gemma":[0.00016131539,0.00006705239,0.000040905867,0.00021284314,0.0005755208,0.000008182657,0.0006206014,0.00027375476,0.000002462444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055412518,0.000090977555,0.0059832754,0.00025859982,0.00016632283,0.0000024618087,0.00075444084,0.000013668894,0.9418776,0.008885958,0.02101307,0.02089818],"study_design_scores_gemma":[0.0007766583,0.0002800849,0.005485443,0.00076504063,0.000073591495,0.000018930947,0.001721344,0.004481773,0.7813584,0.002307928,0.20214413,0.0005866509],"about_ca_topic_score_codex":0.0007729778,"about_ca_topic_score_gemma":0.0004889984,"teacher_disagreement_score":0.18113106,"about_ca_system_score_codex":0.000036825008,"about_ca_system_score_gemma":0.00033288889,"threshold_uncertainty_score":0.40739074},"labels":[],"label_agreement":null},{"id":"W4403966709","doi":"10.1158/2767-9764.crc-23-0489","title":"Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovative Targeting Solutions (Canada)","funders":"National Cancer Institute","keywords":"Stromal cell; Biology; Pancreatic cancer; Tumor microenvironment; Cancer research; Interactome; Cancer-Associated Fibroblasts; Stroma; Context (archaeology); Fibroblast; Cancer; Computational biology; Immunology; Genetics; Cell culture; Tumor cells; Gene; Immunohistochemistry","score_opus":0.07016927760145636,"score_gpt":0.3771237749787284,"score_spread":0.30695449737727204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403966709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9301007,0.065703005,0.000985192,0.00043485264,0.00007018901,0.0003163528,0.00034708396,0.000018926223,0.0020237502],"genre_scores_gemma":[0.99117935,0.0065257023,0.0004978458,0.000009675247,0.0000306008,0.00013766496,0.00016892051,0.000031168132,0.0014190921],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867845,0.00026107277,0.0003226923,0.00024410312,0.00024249153,0.0002512237],"domain_scores_gemma":[0.99840003,0.00008913004,0.000072884184,0.0010085113,0.00036219065,0.000067279034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043233638,0.000107867265,0.00017203494,0.0001268104,0.00017702984,0.000024330306,0.0006977923,0.00011200003,0.000039959752],"category_scores_gemma":[0.000055563265,0.000110350746,0.00008968309,0.00039699324,0.00046610984,0.000009942684,0.00020633228,0.00028503346,0.0000022274357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000226854,0.000091582,0.0006578055,0.000352156,0.000060637034,2.2648275e-7,0.00021720145,0.00008136723,0.99531204,0.00020703244,0.0018886349,0.0011086476],"study_design_scores_gemma":[0.00047990988,0.00047148074,0.00047954396,0.0011502908,0.00006859759,0.0000016250268,0.00038612232,0.0043777865,0.98246896,0.0005202384,0.009354392,0.00024106239],"about_ca_topic_score_codex":0.003282044,"about_ca_topic_score_gemma":0.0020131497,"teacher_disagreement_score":0.06107868,"about_ca_system_score_codex":0.00038463384,"about_ca_system_score_gemma":0.000563193,"threshold_uncertainty_score":0.49614906},"labels":[],"label_agreement":null},{"id":"W4405072689","doi":"10.1158/2767-9764.crc-24-0522","title":"Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Regional Cancer Foundation; Vancouver General Hospital; Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; University of British Columbia; Canadian Cancer Society; University Health Network","funders":"Health Innovation Network South London; AstraZeneca","keywords":"Internal medicine; Oncology; Medicine; Adverse effect; Chemotherapy","score_opus":0.04004157953203048,"score_gpt":0.395896123513038,"score_spread":0.3558545439810075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405072689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941278,0.0010958631,0.000003422936,0.003597755,0.000009109158,0.0008827352,0.000077849756,0.00001654874,0.00018892124],"genre_scores_gemma":[0.99698615,0.0015594647,0.00025238394,0.000016684806,0.000009295268,0.00033917802,0.000049181897,0.000022590557,0.00076504983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983586,0.00023159572,0.00021514246,0.0002205353,0.0006777262,0.0002963689],"domain_scores_gemma":[0.9985175,0.00036608538,0.000054691038,0.00048935506,0.00044313472,0.00012922149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054327055,0.000112908594,0.00027668328,0.0004031083,0.00013946879,0.000013615357,0.00018452224,0.00006265293,0.000024774372],"category_scores_gemma":[0.00013062048,0.00007760057,0.0000254654,0.0005056437,0.00019777776,0.0001626795,0.00025492796,0.0004379671,0.0000038915905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041915913,0.00029783897,0.9942224,0.00021263043,0.00029793437,0.000016478885,0.0010513553,0.0000087869585,0.00025678685,0.00017459405,0.000052734966,0.002989309],"study_design_scores_gemma":[0.0032334365,0.0007011931,0.9924624,0.0006514716,0.00006549031,0.000006260168,0.00031914626,0.0016107041,0.0005934319,0.000054705917,0.00021452579,0.00008726242],"about_ca_topic_score_codex":0.00057888974,"about_ca_topic_score_gemma":0.0005397186,"teacher_disagreement_score":0.0035810703,"about_ca_system_score_codex":0.0013530294,"about_ca_system_score_gemma":0.00076512014,"threshold_uncertainty_score":0.3538125},"labels":[],"label_agreement":null},{"id":"W4405189264","doi":"10.1158/2767-9764.crc-24-0568","title":"First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid Malignancies","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Tolerability; Pharmacodynamics; Adverse effect; Medicine; Rash; Pharmacokinetics; Dosing; Immune system; Cmax; Internal medicine; Oncology; Pharmacology; Maximum tolerated dose; Immunology","score_opus":0.22607191293560108,"score_gpt":0.4938563121146675,"score_spread":0.26778439917906643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405189264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953679,0.00028926213,0.0005936015,0.0011435203,0.000076259654,0.0022032703,0.00007473586,0.000088741326,0.000162751],"genre_scores_gemma":[0.9967108,0.00091927807,0.00041928215,0.000035282763,0.000018355231,0.0016397825,0.000031573167,0.00004947472,0.00017616995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99667585,0.0009177434,0.00072908244,0.00057099265,0.00054122834,0.0005651305],"domain_scores_gemma":[0.99710536,0.0007806864,0.000097799006,0.0016018586,0.00028541588,0.00012886606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011450513,0.00017401604,0.00029735043,0.0005506823,0.00049526355,0.00017886436,0.0011780297,0.000048068978,0.000050517498],"category_scores_gemma":[0.0005725228,0.00016161964,0.00004072089,0.001495814,0.00036660637,0.00033538014,0.00029417593,0.00046523206,0.000008233925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012269628,0.0008490748,0.00033732984,0.00009571987,0.000006505614,0.000019480154,0.0017368395,0.0045854226,0.9815848,0.01031915,0.000007252815,0.00033576455],"study_design_scores_gemma":[0.0017904076,0.0015349538,0.0045917947,0.00031332325,0.000016736642,0.0000042312813,0.0007398455,0.06471703,0.9244234,0.0009606667,0.00067407585,0.00023354737],"about_ca_topic_score_codex":0.00020007971,"about_ca_topic_score_gemma":0.004325156,"teacher_disagreement_score":0.060131613,"about_ca_system_score_codex":0.00012326904,"about_ca_system_score_gemma":0.00033231592,"threshold_uncertainty_score":0.6590657},"labels":[],"label_agreement":null},{"id":"W4405797009","doi":"10.1158/2767-9764.crc-24-0287","title":"Clinical Proteomics Reveals Vulnerabilities in Noninvasive Breast Ductal Carcinoma and Drives Personalized Treatment Strategies","year":2024,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba; IGNIS Innovation (Canada); Jewish General Hospital; Research Institute in Oncology and Hematology; McGill University; CancerCare Manitoba","funders":"National Cancer Institute; Warren Y. Soper Charitable Trust; Fondation De Famille Alvin Segal; Jewish General Hospital; Fondation du cancer du sein du Québec; Genome Canada; Faculty of Medicine, McGill University; McGill University","keywords":"Druggability; Proteomics; Breast cancer; Ductal carcinoma; PI3K/AKT/mTOR pathway; Biology; Quantitative proteomics; Cancer; Bioinformatics; Cancer research; Medicine; Computational biology; Oncology; Pathology; Internal medicine; Gene; Signal transduction; Genetics","score_opus":0.12778570349092808,"score_gpt":0.4749458926351294,"score_spread":0.3471601891442013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405797009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97000563,0.014473275,0.00047949606,0.0069380896,0.000018705763,0.0009294141,0.00064170535,0.00016690191,0.006346792],"genre_scores_gemma":[0.9533595,0.022543373,0.016750026,0.000012283516,0.00010643706,0.005541406,0.000092316724,0.000034161996,0.0015605028],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9984229,0.00022497385,0.00039840656,0.00042989932,0.00018505692,0.00033876929],"domain_scores_gemma":[0.9974882,0.00091140176,0.000047094967,0.0012375423,0.00019349808,0.0001222668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060430623,0.00016024536,0.00024330415,0.00013171938,0.00038665402,0.00021875271,0.00061201764,0.000125036,0.00018318238],"category_scores_gemma":[0.00007042358,0.00014669338,0.00008386105,0.00031789517,0.0013868199,0.00023450727,0.00039010748,0.0008356748,0.000007704354],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019524792,0.00088771293,0.07975078,0.0008997502,0.00025038185,0.000048011407,0.01214653,0.00004397197,0.19019148,0.6740063,0.0007931407,0.04078675],"study_design_scores_gemma":[0.005879496,0.0009380072,0.023367543,0.0049112146,0.0002325436,0.0006617399,0.07385136,0.019758368,0.0717783,0.6048153,0.19093767,0.0028684426],"about_ca_topic_score_codex":0.00127296,"about_ca_topic_score_gemma":0.0010033648,"teacher_disagreement_score":0.19014452,"about_ca_system_score_codex":0.0005436732,"about_ca_system_score_gemma":0.00074422604,"threshold_uncertainty_score":0.59819824},"labels":[],"label_agreement":null},{"id":"W4406215254","doi":"10.1158/2767-9764.crc-24-0566","title":"Evaluating Ovarian Cancer Risk–Reducing Salpingectomy Acceptance: A Survey","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cancer Research; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Salpingectomy; Ovarian cancer; Medicine; Population; Gynecology; Demography; Obstetrics; Incidence (geometry); Risk assessment; Cancer; Oncology; Environmental health; Internal medicine; Pregnancy; Biology","score_opus":0.36091268936756304,"score_gpt":0.5806585139827994,"score_spread":0.2197458246152364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406215254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6737976,0.16246909,0.00053051644,0.10171184,0.0010816719,0.005893144,0.0012599294,0.00038491466,0.052871324],"genre_scores_gemma":[0.9464641,0.04222533,0.0034971,0.00038232724,0.0001474526,0.0047428734,0.0001231052,0.00003934537,0.002378329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620444,0.0014836229,0.00044732186,0.00054896326,0.0006834594,0.00063219276],"domain_scores_gemma":[0.9932791,0.00180482,0.00013651,0.0030709847,0.0014892648,0.00021932035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036843256,0.00020069067,0.0004062938,0.00044361246,0.0012969866,0.00014281162,0.0009309355,0.00011611568,0.0009825851],"category_scores_gemma":[0.0016825347,0.00018660317,0.00012403174,0.0022779668,0.00041364483,0.00013580479,0.0006774563,0.0011847223,0.00004509896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000289876,0.00075440423,0.5879011,0.00018294496,0.0010330573,0.0000046515092,0.0010465141,0.00025789207,0.0011256748,0.0029763447,0.029385243,0.37504226],"study_design_scores_gemma":[0.0029506201,0.00015110773,0.9492837,0.0016757768,0.00028635995,0.000001848159,0.0002823384,0.0038432966,0.0012460704,0.0006695698,0.039404247,0.00020506256],"about_ca_topic_score_codex":0.06086401,"about_ca_topic_score_gemma":0.018213946,"teacher_disagreement_score":0.3748372,"about_ca_system_score_codex":0.0019613078,"about_ca_system_score_gemma":0.0034770994,"threshold_uncertainty_score":0.9999307},"labels":[],"label_agreement":null},{"id":"W4406327402","doi":"10.1158/2767-9764.crc-24-0386","title":"Loss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann Cells","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"GNAQ; Carcinogenesis; Melanoma; Cancer research; Biology; Pathology; Medicine; Cancer; Mutation; Genetics; Gene","score_opus":0.08542991706878349,"score_gpt":0.4099424133787871,"score_spread":0.3245124963100036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406327402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96396637,0.023458911,0.000010258851,0.008706113,0.000031037634,0.00052374066,0.000083610816,0.000024902534,0.0031950297],"genre_scores_gemma":[0.9774895,0.021400297,0.00039178185,0.00010043585,0.000021962382,0.00016637713,0.00001989695,0.000015309386,0.00039446662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986788,0.00020244547,0.00032286654,0.00023294642,0.00027218706,0.00029076493],"domain_scores_gemma":[0.99813086,0.00045326463,0.000043138294,0.00091759907,0.00029217216,0.00016297001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045016117,0.00011775127,0.00030307015,0.00027226843,0.0003844741,0.000055557026,0.00038186545,0.000072230905,0.00005271802],"category_scores_gemma":[0.000066517314,0.000100460136,0.00005268909,0.00053996086,0.00093718845,0.000120903744,0.00030947285,0.0004459851,0.0000027109916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005999661,0.00068524224,0.10470491,0.0014850304,0.00040110305,0.000055064444,0.0013175338,0.00000260832,0.82383513,0.028889343,0.003672808,0.034351245],"study_design_scores_gemma":[0.0028651748,0.0007066837,0.19084176,0.0009983812,0.00018587243,0.00011198068,0.0013182627,0.00040930053,0.74190414,0.0011006182,0.059274238,0.00028356072],"about_ca_topic_score_codex":0.00045600184,"about_ca_topic_score_gemma":0.00013196867,"teacher_disagreement_score":0.086136855,"about_ca_system_score_codex":0.000066216606,"about_ca_system_score_gemma":0.0005522718,"threshold_uncertainty_score":0.40966454},"labels":[],"label_agreement":null},{"id":"W4406687228","doi":"10.1158/2767-9764.crc-24-0403","title":"Development of a Microvessel Density Gene Signature and Its Application in Precision Medicine","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"Eisai","keywords":"Signature (topology); Computational biology; Computer science; Biology; Mathematics","score_opus":0.06631634063185135,"score_gpt":0.42921370317800184,"score_spread":0.36289736254615046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406687228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9232893,0.07155195,0.0017117073,0.0021077965,0.000021596976,0.00042277123,0.0000108219065,0.0000036114816,0.0008804588],"genre_scores_gemma":[0.9831057,0.013824329,0.0023644085,0.000074179,0.000020157093,0.00026857088,0.000057811194,0.000005447567,0.000279393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992967,0.000103397644,0.00018731812,0.00017917097,0.00011489112,0.00011847184],"domain_scores_gemma":[0.99895376,0.000053244417,0.00003973872,0.0005906681,0.00033130075,0.000031262978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006179759,0.0000560848,0.000096970376,0.00011228989,0.0001397562,0.0000042050615,0.00040819458,0.00008690519,0.0000047136223],"category_scores_gemma":[0.000100390425,0.000051308478,0.000014640405,0.00032301663,0.00015609288,0.000002814685,0.00047145333,0.0001268496,6.7094135e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003464054,0.00004068424,0.0022185687,0.000031788622,0.000019691977,4.0868766e-8,0.00018512183,0.000003549777,0.9660452,0.0007397153,0.0007808901,0.029900102],"study_design_scores_gemma":[0.00044626227,0.000029371402,0.034071837,0.00018210008,0.000007462159,4.844997e-7,0.00020766586,0.00024038268,0.8314661,0.00026855312,0.13299659,0.00008322888],"about_ca_topic_score_codex":0.00012383857,"about_ca_topic_score_gemma":0.0014419794,"teacher_disagreement_score":0.13457914,"about_ca_system_score_codex":0.000056416666,"about_ca_system_score_gemma":0.00030038765,"threshold_uncertainty_score":0.2092299},"labels":[],"label_agreement":null},{"id":"W4407081872","doi":"10.1158/2767-9764.crc-24-0601","title":"Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; F. Hoffmann-La Roche","keywords":"Pembrolizumab; Metastatic melanoma; Medicine; Oncology; Melanoma; Internal medicine; Immunotherapy; Cancer research; Cancer","score_opus":0.15698857520298767,"score_gpt":0.5087172314434762,"score_spread":0.35172865624048855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407081872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98982346,0.002734144,0.00018609608,0.0037164895,0.0000054531138,0.002488291,0.00021081686,0.00002075893,0.00081450323],"genre_scores_gemma":[0.9924467,0.0021499128,0.0013049166,0.000035314228,0.000005747154,0.001985325,0.0001420113,0.000014868493,0.0019151819],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986369,0.00023559864,0.00041258815,0.00020665534,0.0002975003,0.0002107533],"domain_scores_gemma":[0.9966603,0.0007817244,0.00012601285,0.0014535623,0.0008857785,0.00009261962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032385506,0.00012768577,0.00055712985,0.00045598397,0.00025472452,0.000013010363,0.0002748526,0.000025901449,0.00008462821],"category_scores_gemma":[0.00017341338,0.0000889849,0.000082528786,0.0009653236,0.00041219377,0.00006204122,0.00012286303,0.000116324285,7.0203765e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.121730775,0.16185805,0.009127805,0.0035531947,0.016886294,0.0000647261,0.021492204,0.00035294815,0.28523204,0.013741963,0.0026696415,0.36329037],"study_design_scores_gemma":[0.46896383,0.19643657,0.01527348,0.007385116,0.0062463605,0.00003624519,0.07684147,0.017998029,0.16787682,0.0015816592,0.040412936,0.0009474728],"about_ca_topic_score_codex":0.0007255431,"about_ca_topic_score_gemma":0.0021056377,"teacher_disagreement_score":0.3623429,"about_ca_system_score_codex":0.00021551955,"about_ca_system_score_gemma":0.000565015,"threshold_uncertainty_score":0.3628699},"labels":[],"label_agreement":null},{"id":"W4407296520","doi":"10.1158/2767-9764.crc-24-0407","title":"Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bayer","keywords":"Nivolumab; Medicine; Tolerability; Adverse effect; Oncology; Internal medicine; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Cancer; Clinical trial; Immunotherapy","score_opus":0.04313230397912114,"score_gpt":0.43944991981068704,"score_spread":0.3963176158315659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407296520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931879,0.0023714148,0.000015209704,0.0013370994,0.000009837899,0.0023707063,0.000020172041,0.000011523698,0.00067615224],"genre_scores_gemma":[0.9977062,0.0015952364,0.00017427719,0.00004135142,0.0000020556427,0.00032941572,0.000044804896,0.000012163958,0.00009449316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985916,0.0002971826,0.00034534535,0.00020480448,0.00034874148,0.0002123141],"domain_scores_gemma":[0.9981881,0.00031071494,0.00007798345,0.00094641256,0.00042950222,0.00004731072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068986666,0.00009516373,0.00029029412,0.00043169432,0.00013771767,0.000014477071,0.00030119464,0.0000317445,0.00001692664],"category_scores_gemma":[0.00011162482,0.0000770924,0.000015927018,0.0016060885,0.00048376527,0.00010591019,0.00014490765,0.00040517238,3.1398852e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03964227,0.009688966,0.8305689,0.00012764249,0.00017334118,0.000003758913,0.0031783425,0.000036721525,0.00070394285,0.00027235315,0.0000828999,0.11552087],"study_design_scores_gemma":[0.053669833,0.0031144388,0.9391959,0.0011838406,0.000021001939,3.4922024e-7,0.0016150606,0.00020179665,0.0001844626,0.000019268451,0.0007162889,0.00007780995],"about_ca_topic_score_codex":0.002018167,"about_ca_topic_score_gemma":0.007643855,"teacher_disagreement_score":0.115443066,"about_ca_system_score_codex":0.0004518909,"about_ca_system_score_gemma":0.0005991712,"threshold_uncertainty_score":0.42654505},"labels":[],"label_agreement":null},{"id":"W4407803354","doi":"10.1158/2767-9764.crc-24-0638","title":"Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); BC Cancer Agency; Princess Margaret Cancer Centre; University Health Network; Ottawa Hospital","funders":"Genentech; Symphogen; BeiGene; AstraZeneca; Pfizer","keywords":"Atezolizumab; Medicine; Solid tumor; Cancer research; Oncology; Internal medicine; Cancer; Immunotherapy; Nivolumab","score_opus":0.04126457459301598,"score_gpt":0.33491896054358083,"score_spread":0.29365438595056487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407803354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467784,0.0023267714,0.000051145154,0.0013531195,0.000020916184,0.000599953,0.00003473557,0.000010921762,0.0009245845],"genre_scores_gemma":[0.9983147,0.0009918236,0.00008078959,0.000029987137,9.135954e-7,0.00012629449,0.00005004547,0.0000094249,0.00039603672],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987581,0.00041448418,0.00023129673,0.0002381387,0.000060845738,0.00029714152],"domain_scores_gemma":[0.9987463,0.00032297257,0.00008769278,0.00062592136,0.00019925207,0.000017903634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032998255,0.000114390685,0.00028139708,0.00041059178,0.00022836494,0.000015589449,0.0003508545,0.000100595826,0.000017154995],"category_scores_gemma":[0.00007903349,0.000094141375,0.00001367026,0.00055198325,0.0011135549,0.00010269699,0.00043820386,0.00053896866,0.0000023854084],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066056293,0.004878626,0.23955326,0.00014930418,0.0002559059,0.000003372713,0.0022507892,0.000025518004,0.7123233,0.003850597,0.00010061946,0.030003058],"study_design_scores_gemma":[0.017961523,0.0013514389,0.91667604,0.0009776378,0.000031254214,0.000008729947,0.0006798693,0.00010255922,0.058950827,0.00025208204,0.0027558594,0.00025219272],"about_ca_topic_score_codex":0.0024610022,"about_ca_topic_score_gemma":0.0061138887,"teacher_disagreement_score":0.6771228,"about_ca_system_score_codex":0.00019166799,"about_ca_system_score_gemma":0.0002527811,"threshold_uncertainty_score":0.41029394},"labels":[],"label_agreement":null},{"id":"W4410313621","doi":"10.1158/2767-9764.crc-24-0565","title":"First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"GDF15 and Related Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre","funders":"Eisai; AstraZeneca","keywords":"Antibody; Medicine; Oncology; Solid tumor; Internal medicine; Expanded access; Cancer research; Cancer; Immunology","score_opus":0.05366742063695047,"score_gpt":0.47217865033405315,"score_spread":0.4185112296971027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410313621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888646,0.001419961,0.0000073860156,0.0056391982,0.000017365124,0.0029316666,0.000013215596,0.00000987716,0.0010967236],"genre_scores_gemma":[0.99840194,0.0010371754,0.00014164658,0.000056599663,0.0000028047705,0.0001629196,0.000026415839,0.000013157725,0.0001573253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980171,0.00056548585,0.00041661217,0.00023756792,0.00045733037,0.0003059268],"domain_scores_gemma":[0.9974433,0.0005618366,0.00004950264,0.001434243,0.00042335482,0.000087730434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015685215,0.00011188789,0.0003266325,0.00051056384,0.000349232,0.000017221888,0.0005714611,0.000026324176,0.000017999213],"category_scores_gemma":[0.0003625948,0.00007177601,0.000026203492,0.0018108344,0.00047859922,0.000054200318,0.0004821351,0.000588092,0.0000025297077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011448046,0.0027143487,0.9860022,0.00013654897,0.00020734286,0.0000055896435,0.0035906043,0.00069450826,0.0006093439,0.00025998693,0.00012125527,0.0045134635],"study_design_scores_gemma":[0.0060068183,0.00071073475,0.9888233,0.0012440464,0.000053482192,4.1446583e-7,0.002155626,0.00034114704,0.000058492507,0.00005194239,0.00048406824,0.00006991323],"about_ca_topic_score_codex":0.0009784575,"about_ca_topic_score_gemma":0.0022650948,"teacher_disagreement_score":0.0095373485,"about_ca_system_score_codex":0.00020801181,"about_ca_system_score_gemma":0.00031681926,"threshold_uncertainty_score":0.29269406},"labels":[],"label_agreement":null},{"id":"W4412155405","doi":"10.1158/2767-9764.crc-25-0080","title":"Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Hospital for Sick Children; Children's Hospital of Eastern Ontario; McGill University; University of Calgary; Ontario Institute for Cancer Research; University of Toronto; Dalhousie University","funders":"","keywords":"Zebrafish; Medicine; Oncology; Internal medicine; Biology; Genetics; Gene","score_opus":0.06799869772182086,"score_gpt":0.44204287711510293,"score_spread":0.37404417939328205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412155405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593008,0.008728789,0.0063795564,0.018282782,0.00008392386,0.0019186812,0.00015536306,0.00003611251,0.005113956],"genre_scores_gemma":[0.9366578,0.057428174,0.0016301868,0.0004345366,0.00010022092,0.0030095433,0.00012875666,0.000020593712,0.00059019506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977735,0.0003584996,0.00035185163,0.00041293545,0.00053421606,0.0005689673],"domain_scores_gemma":[0.99653536,0.00023373119,0.000034999455,0.0022910705,0.00065224036,0.00025260396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017161666,0.00012788134,0.00014983366,0.0006199066,0.0005509787,0.00008001736,0.0022184786,0.0001585557,0.000050592607],"category_scores_gemma":[0.001551702,0.00012673213,0.000055759243,0.0027900406,0.00022415009,0.000013920637,0.0014482406,0.00072577567,0.00003813627],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011985957,0.0011703392,0.034123167,0.00013786298,0.00032030794,0.000002176208,0.001100716,0.0291294,0.12956224,0.013140766,0.13330312,0.6568113],"study_design_scores_gemma":[0.0039930306,0.0006792005,0.03565528,0.00024566636,0.000023846549,8.7035875e-7,0.0007511663,0.039492454,0.020283941,0.010914029,0.8871747,0.00078580156],"about_ca_topic_score_codex":0.006542263,"about_ca_topic_score_gemma":0.010597555,"teacher_disagreement_score":0.7538716,"about_ca_system_score_codex":0.00045538307,"about_ca_system_score_gemma":0.0017323237,"threshold_uncertainty_score":0.98899883},"labels":[],"label_agreement":null},{"id":"W4412974237","doi":"10.1158/2767-9764.crc-25-0019","title":"Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Alberta; Spinal Cord Injury BC; Ontario Institute for Cancer Research; Jewish General Hospital; BC Cancer Agency; Princess Margaret Cancer Centre","funders":"Merck Canada; National Cancer Institute; Incyte; Memorial Sloan-Kettering Cancer Center; BeiGene; AstraZeneca; Celgene; Gilead Sciences","keywords":"Medicine; Internal medicine; Discontinuation; Nausea; Adverse effect; Oncology; Breast cancer; Metastatic breast cancer; Response Evaluation Criteria in Solid Tumors; Cancer; Clinical endpoint; Phases of clinical research; Gastroenterology; Chemotherapy; Clinical trial","score_opus":0.3892141963931314,"score_gpt":0.6154104701398585,"score_spread":0.22619627374672713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412974237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98142564,0.0030458756,0.00003148985,0.0062540937,0.000025594129,0.002686421,0.000033297256,0.000028648281,0.006468934],"genre_scores_gemma":[0.9949704,0.00095168134,0.00042503062,0.00008557334,0.000013322975,0.0024533737,0.000014975334,0.0000284233,0.0010572214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961445,0.0011464101,0.00059950695,0.0003440523,0.0010451262,0.0007204466],"domain_scores_gemma":[0.9949199,0.0009438841,0.000080255,0.0029221582,0.0009163863,0.0002173915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025486022,0.00014111736,0.0005243769,0.00088416337,0.00022630891,0.000034864774,0.0011698998,0.000038304486,0.00022120171],"category_scores_gemma":[0.0010342408,0.00011961928,0.000041838168,0.00311514,0.00073728146,0.00009283978,0.0006501411,0.0011904008,0.00001980137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012236054,0.112747334,0.5958285,0.003792186,0.0030781936,0.0005054843,0.04623969,0.0010386292,0.045067426,0.009815471,0.0203794,0.14927165],"study_design_scores_gemma":[0.18068753,0.04287939,0.4033544,0.02201522,0.0013818125,0.000044670414,0.16781844,0.03963493,0.073683634,0.0042584646,0.062420785,0.0018206987],"about_ca_topic_score_codex":0.00673787,"about_ca_topic_score_gemma":0.013715127,"teacher_disagreement_score":0.19247408,"about_ca_system_score_codex":0.00070830766,"about_ca_system_score_gemma":0.0031812578,"threshold_uncertainty_score":0.9998763},"labels":[],"label_agreement":null},{"id":"W4415280517","doi":"10.1158/2767-9764.crc-25-0305","title":"The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404)","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute; AstraZeneca; Bristol-Myers Squibb; Eli Lilly and Company; Pharmaceuticals Bayer; Ipsen; Astellas Pharma; Eisai; Gilead Sciences; Pfizer; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Cisplatin; Solid tumor; Clinical trial; Cancer; Phases of clinical research; Ataxia-telangiectasia","score_opus":0.02733874823644689,"score_gpt":0.3955000211396913,"score_spread":0.3681612729032444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415280517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387676,0.0013442753,0.000086672604,0.0021570509,0.000061548,0.0019857804,0.00009732718,0.000014755782,0.00037584992],"genre_scores_gemma":[0.9949703,0.0008927733,0.00029219355,0.00009607992,0.000025264955,0.003200325,0.00017758313,0.000024794917,0.0003206633],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979988,0.0005114763,0.00036904126,0.00033312463,0.00036787425,0.00041970587],"domain_scores_gemma":[0.9976775,0.00016633046,0.00011197449,0.0013847537,0.0005882142,0.00007123461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077928207,0.0001470103,0.00018515944,0.00017739301,0.0003660409,0.00006044773,0.0008373153,0.00009063114,0.000010147903],"category_scores_gemma":[0.00032345994,0.00010940322,0.000030999032,0.0007711619,0.0003934152,0.000016526414,0.00040589913,0.00046739183,0.0000027705235],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2821341,0.015149097,0.22019972,0.00038416678,0.0008721177,0.00001776516,0.002281244,0.003392658,0.2874394,0.00803822,0.010379636,0.16971186],"study_design_scores_gemma":[0.471415,0.014686343,0.063229166,0.0039708707,0.00013040868,0.0000022137765,0.0032605664,0.006873728,0.28755882,0.001983708,0.14497262,0.0019165244],"about_ca_topic_score_codex":0.0005773156,"about_ca_topic_score_gemma":0.019830834,"teacher_disagreement_score":0.18928093,"about_ca_system_score_codex":0.00033221525,"about_ca_system_score_gemma":0.0011144952,"threshold_uncertainty_score":0.9980547},"labels":[],"label_agreement":null},{"id":"W4415437777","doi":"10.1158/2767-9764.crc-25-0346","title":"Continuous versus Standard Palbociclib Treatment and Molecular Profiling of Solid Tissues and Liquid Biopsies in the CCTG MA.38 Trial in Advanced Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University of Waterloo; Wilfrid Laurier University; Université Laval; Centre hospitalier de l'Université Laval; Kingston Health Sciences Centre; Interior Health; University Health Network; Ottawa Hospital; Centre hospitalier universitaire de Québec; BC Cancer Agency; Research Canada; University of Alberta; University of Toronto; Toronto Public Health; Cancer Care South East; Public Health Ontario; Ontario Institute for Cancer Research","funders":"Canadian Cancer Society; Pfizer Canada; Government of Ontario; Memorial Sloan-Kettering Cancer Center; Pfizer","keywords":"Palbociclib; Liquid biopsy; Dosing; Breast cancer; Profiling (computer programming); Clinical trial","score_opus":0.08343511337705574,"score_gpt":0.48942236705346986,"score_spread":0.40598725367641414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415437777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91802,0.06153948,0.000023035276,0.0175569,0.00005744568,0.0020410193,0.00025077592,0.000018663348,0.00049266923],"genre_scores_gemma":[0.9643489,0.032453563,0.0008229794,0.0000616696,0.000028116543,0.0021620756,0.000016483687,0.000017719345,0.00008850158],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983488,0.00041599644,0.0003482042,0.00026791534,0.00028220747,0.00033689576],"domain_scores_gemma":[0.9979497,0.0006513501,0.00007623749,0.00097340974,0.00028794407,0.00006131562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006484568,0.00015052831,0.0004201988,0.00030993778,0.0001612826,0.000024746447,0.00036373507,0.00006787025,0.000017988714],"category_scores_gemma":[0.00015857304,0.000114939234,0.000038150603,0.00074181025,0.00085408136,0.00010524604,0.00023749706,0.00040104365,2.7048884e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42493826,0.0015226954,0.022927614,0.00074748986,0.0008853575,0.000045673278,0.020487174,0.0002901012,0.10901184,0.012255815,0.000091198766,0.40679678],"study_design_scores_gemma":[0.521468,0.016383093,0.054778174,0.01059099,0.00063476193,0.00006893055,0.090961166,0.0012370679,0.19980764,0.006334464,0.096288204,0.0014475394],"about_ca_topic_score_codex":0.0016655738,"about_ca_topic_score_gemma":0.0037815247,"teacher_disagreement_score":0.40534925,"about_ca_system_score_codex":0.00056515617,"about_ca_system_score_gemma":0.0006562153,"threshold_uncertainty_score":0.4687086},"labels":[],"label_agreement":null},{"id":"W4416369016","doi":"10.1158/2767-9764.crc-25-0564","title":"Cancer Incidence and Mortality Estimates in Latin America and the Caribbean: A Systematic Analysis of the GLOBOCAN 2022","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cancer; Lung cancer; Prostate cancer; Breast cancer; Latin Americans; Incidence (geometry); Colorectal cancer; Epidemiology","score_opus":0.17848345404839586,"score_gpt":0.5065015263874924,"score_spread":0.3280180723390965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416369016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88458866,0.08458318,0.000063242805,0.027274603,0.000032435095,0.0015577811,0.00006917091,0.000012484529,0.0018184653],"genre_scores_gemma":[0.9875732,0.010842872,0.00014520867,0.00038373691,0.000005633828,0.0009002057,0.0000044595113,0.0000040711234,0.00014062847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803114,0.00073582947,0.00037469214,0.0001864743,0.00046445022,0.00020739513],"domain_scores_gemma":[0.99631,0.0015599229,0.00012210768,0.0015715825,0.0003811031,0.000055282715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016662333,0.00008595814,0.00048624768,0.00024384976,0.0003633615,0.000041479052,0.00070061575,0.00003819911,0.000022443894],"category_scores_gemma":[0.0015827782,0.000050452312,0.00007521089,0.0036248101,0.0017338669,0.00006250373,0.00082572683,0.0004750959,2.3269608e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009653793,0.000033931057,0.98423994,0.0015053181,0.000919708,0.0000010801106,0.0030221927,0.00035917273,0.00031512394,0.007827337,0.00035887596,0.0013208024],"study_design_scores_gemma":[0.0005875277,0.000017675247,0.9424376,0.004332588,0.0012416744,0.000001151421,0.004024637,0.046082754,0.00007732265,0.001003615,0.00013310846,0.00006035344],"about_ca_topic_score_codex":0.097440384,"about_ca_topic_score_gemma":0.078408666,"teacher_disagreement_score":0.10298455,"about_ca_system_score_codex":0.00028460144,"about_ca_system_score_gemma":0.00055204215,"threshold_uncertainty_score":0.93840796},"labels":[],"label_agreement":null},{"id":"W4417247612","doi":"10.1158/2767-9764.crc-25-0419","title":"Extrachromosomal microDNA Signature as a Candidate Biomarker in Pediatric Acute Lymphoblastic Leukemia","year":2025,"lang":"en","type":"article","venue":"Cancer Research Communications","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; National Research Council Canada; Centre Hospitalier Universitaire Sainte-Justine; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Centre de recherche du CHU Sainte-Justine; Leukemia and Lymphoma Society of Canada; Canadian Cancer Society; Leukemia and Lymphoma Society","keywords":"Disease; Biomarker; Lymphoblastic Leukemia; Signature (topology); Acute lymphocytic leukemia; Gene","score_opus":0.044408700586863935,"score_gpt":0.41466590033909495,"score_spread":0.37025719975223104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417247612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8969551,0.025267221,0.00028942866,0.028181933,0.00026033403,0.002971575,0.00024981113,0.00021334137,0.045611292],"genre_scores_gemma":[0.9716419,0.01728353,0.0008764678,0.00057681947,0.00009413096,0.0013226129,0.00018086219,0.000057894693,0.00796578],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9957958,0.00074854074,0.0005906634,0.0006590176,0.001034399,0.001171589],"domain_scores_gemma":[0.9936726,0.0017735296,0.000080729085,0.0031421261,0.00093688926,0.0003941464],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013957353,0.00028505235,0.00048909185,0.0017995215,0.00057411386,0.0001221322,0.0020432957,0.00035572314,0.0004711771],"category_scores_gemma":[0.0012786393,0.0002680811,0.00013651923,0.0050032525,0.0009316598,0.0002007445,0.0017058492,0.0020173932,0.00030041873],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0068136826,0.003311984,0.12555365,0.0027912804,0.0025270209,0.002092017,0.003339773,0.00017200057,0.38105765,0.023566708,0.39022353,0.05855068],"study_design_scores_gemma":[0.03721511,0.0010670824,0.5955639,0.004698868,0.001463322,0.00063822063,0.0015537961,0.046930384,0.016163051,0.007018389,0.2857058,0.001982075],"about_ca_topic_score_codex":0.004514731,"about_ca_topic_score_gemma":0.0016769788,"teacher_disagreement_score":0.47001022,"about_ca_system_score_codex":0.00840861,"about_ca_system_score_gemma":0.01597383,"threshold_uncertainty_score":0.9999771},"labels":[],"label_agreement":null}]}